reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD010632-bib-0001,"Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Kerrouche N, at al. ",Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease, Archives of Neurology ,2005,62,    ,['citation-journal']," Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Kerrouche N, at al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.  Archives of Neurology 2005;62(11):1728‐33.    Link to article     Google Scholar     ","['https://doi.org/10.1001/archneur.62.11.1728', 'https://scholar.google.com/scholar_lookup?title=Heterogeneity+of+brain+glucose+metabolism+in+mild+cognitive+impairment+and+clinical+progression+to+Alzheimer+disease+&author=D+Anchisi&author=B+Borroni&author=M+Franceschi&author=N+Kerrouche&author=E+Kalbe&author=N+Kerrouche&author=al+at&publication_year=2005&hl=en']",,https://doi.org/10.1001/archneur.62.11.1728, Anchisi 2005 {published data only}  ,included,CD010632-bbs2-0001,
CD010632-bib-0002,"Arnáiz E, Jelic V, Almkvist O, Wahlund L‐O, Winbald B, Valind S, et al. ",Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment, Neuroreport ,2001,12,    ,['citation-journal']," Arnáiz E, Jelic V, Almkvist O, Wahlund L‐O, Winbald B, Valind S, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.  Neuroreport 2001;12(4):851‐5.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00001756-200103260-00045', 'https://scholar.google.com/scholar_lookup?title=Impaired+cerebral+glucose+metabolism+and+cognitive+functioning+predict+deterioration+in+mild+cognitive+impairment+&author=E+Arnáiz&author=V+Jelic&author=O+Almkvist&author=L‐O+Wahlund&author=B+Winbald&author=S+Valind&publication_year=2001&hl=en']",,https://doi.org/10.1097/00001756-200103260-00045, Arnáiz 2001 {published data only}  ,included,CD010632-bbs2-0002,
CD010632-bib-0003,"Berent S, Giordani B, Foster N, Minoshima S, Lajiness‐O'Neill R, Koeppe R, et al. ",Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease, Journal of Psychiatric Research ,1999,33,    ,['citation-journal']," Berent S, Giordani B, Foster N, Minoshima S, Lajiness‐O'Neill R, Koeppe R, et al. Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease.  Journal of Psychiatric Research 1999;33(1):7‐16.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Neuropsychological+function+and+cerebral+glucose+utilization+in+isolated+memory+impairment+and+Alzheimer's+disease+&author=S+Berent&author=B+Giordani&author=N+Foster&author=S+Minoshima&author=R+Lajiness‐O'Neill&author=R+Koeppe&publication_year=1999&hl=en""]",,, Berent 1999 {published data only}  ,included,CD010632-bbs2-0003,
CD010632-bib-0004,"Chételat G, Desgranges B, De la Sayette V, Viadre F, Eustache F, Baron JC. ",Mild cognitive impairment: can FDG‐PET predict who is to rapidly convert to Alzheimer's disease?, Neurology ,2003,60,    ,['citation-journal']," Chételat G, Desgranges B, De la Sayette V, Viadre F, Eustache F, Baron JC. Mild cognitive impairment: can FDG‐PET predict who is to rapidly convert to Alzheimer's disease?.  Neurology 2003;60(8):1374‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1212/01.WNL.0000055847.17752.E6', ""https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment:+can+FDG‐PET+predict+who+is+to+rapidly+convert+to+Alzheimer's+disease?+&author=G+Chételat&author=B+Desgranges&author=V+Sayette&author=F+Viadre&author=F+Eustache&author=JC+Baron&publication_year=2003&hl=en""]",,https://doi.org/10.1212/01.WNL.0000055847.17752.E6, Chételat 2003 {published data only}  ,included,CD010632-bbs2-0004,
CD010632-bib-0005,Clerici F. ,Differences in hippocampal metabolism between amnestic and non‐amnestic MCI subjects: automated FDG‐PET image analysis, Quarterly Journal of Nuclear Medicine and Molecular Imaging ,2009,53,    ,['citation-journal'], Clerici F. Differences in hippocampal metabolism between amnestic and non‐amnestic MCI subjects: automated FDG‐PET image analysis.  Quarterly Journal of Nuclear Medicine and Molecular Imaging 2009;53(6):646‐57.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=Differences+in+hippocampal+metabolism+between+amnestic+and+non‐amnestic+MCI+subjects:+automated+FDG‐PET+image+analysis+&author=F+Clerici&publication_year=2009&hl=en'],,, Clerici 2009 {published data only}  ,included,CD010632-bbs2-0005,
CD010632-bib-0006,"Drzezga A, Grimmer T, Rimenschneider M, Lautenschlager N, Siebner H, Alexopoulus, et al. ",Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F‐FDG PET, Journal of Nuclear Medicine ,2005,46,    ,['citation-journal']," Drzezga A, Grimmer T, Rimenschneider M, Lautenschlager N, Siebner H, Alexopoulus, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F‐FDG PET.  Journal of Nuclear Medicine 2005;46(10):1625‐32.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Prediction+of+individual+clinical+outcome+in+MCI+by+means+of+genetic+assessment+and+(18)F‐FDG+PET+&author=A+Drzezga&author=T+Grimmer&author=M+Rimenschneider&author=N+Lautenschlager&author=H+Siebner&author=+Alexopoulus&publication_year=2005&hl=en'],,, Drzezga 2005 {published data only}  ,included,CD010632-bbs2-0006,
CD010632-bib-0007,"Fellgiebel A, Scheurich A, Bartenstein P, Müller MJ. ",FDG‐PET and CSF phospho‐tau for prediction of cognitive decline in mild cognitive impairment, Psychiatry Research ,2007,155,    ,['citation-journal']," Fellgiebel A, Scheurich A, Bartenstein P, Müller MJ. FDG‐PET and CSF phospho‐tau for prediction of cognitive decline in mild cognitive impairment.  Psychiatry Research 2007;155(2):167‐71.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.pscychresns.2006.12.002', 'https://scholar.google.com/scholar_lookup?title=FDG‐PET+and+CSF+phospho‐tau+for+prediction+of+cognitive+decline+in+mild+cognitive+impairment+&author=A+Fellgiebel&author=A+Scheurich&author=P+Bartenstein&author=MJ+Müller&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.pscychresns.2006.12.002, Fellgiebel 2007 {published data only}  ,included,CD010632-bbs2-0007,
CD010632-bib-0008,"Galluzzi S, Geroldi, C, Ghidoni R, Paghera B, Amicucci B, Bonetti M, et al. ",The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment, Journal of Neurology ,2010,257,    ,['citation-journal']," Galluzzi S, Geroldi, C, Ghidoni R, Paghera B, Amicucci B, Bonetti M, et al. The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment.  Journal of Neurology 2010;257(12):2004–14.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00415-010-5650-0', 'https://scholar.google.com/scholar_lookup?title=The+new+Alzheimer’s+criteria+in+a+naturalistic+series+of+patients+with+mild+cognitive+impairment+&author=S+Galluzzi&author=+Geroldi&author=+C&author=R+Ghidoni&author=B+Paghera&author=B+Amicucci&author=M+Bonetti&publication_year=2010&hl=en']",,https://doi.org/10.1007/s00415-010-5650-0, Galluzzi 2010 {published data only}  ,included,CD010632-bbs2-0008,
CD010632-bib-0009,"Herholz K, Westwood S, Haense C, Dunn G. ",Evaluation of a calibrated (18)F‐FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment, Journal of Nuclear Medicine ,2011,52,    ,['citation-journal']," Herholz K, Westwood S, Haense C, Dunn G. Evaluation of a calibrated (18)F‐FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.  Journal of Nuclear Medicine 2011;52(8):1218‐26.    Link to article     Google Scholar     ","['https://doi.org/10.2967/jnumed.111.090902', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+a+calibrated+(18)F‐FDG+PET+score+as+a+biomarker+for+progression+in+Alzheimer+disease+and+mild+cognitive+impairment+&author=K+Herholz&author=S+Westwood&author=C+Haense&author=G+Dunn&publication_year=2011&hl=en']",,https://doi.org/10.2967/jnumed.111.090902, Herholz 2011 {published data only}  ,included,CD010632-bbs2-0009,
CD010632-bib-0010,"Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, et al. ",Comparing predictors of conversion and decline in mild cognitive impairment, Neurology ,2010,75,    ,['citation-journal']," Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, et al. Comparing predictors of conversion and decline in mild cognitive impairment.  Neurology 2010;75(3):230‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1212/WNL.0b013e3181e8e8b8', 'https://scholar.google.com/scholar_lookup?title=Comparing+predictors+of+conversion+and+decline+in+mild+cognitive+impairment&author=SM+Landau&author=D+Harvey&author=CM+Madison&author=EM+Reiman&author=NL+Foster&author=PS+Aisen&publication_year=2010&hl=en']",,https://doi.org/10.1212/WNL.0b013e3181e8e8b8, Landau 2010 {published data only}  ,included,CD010632-bbs2-0010,
CD010632-bib-0011,"Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. ",MCI conversion to dementia and APOE genotype: a prediction study with FDG‐PET, Neurology ,2004,63,    ,['citation-journal']," Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. MCI conversion to dementia and APOE genotype: a prediction study with FDG‐PET.  Neurology 2004;63(12):2332‐40.    Link to article     Google Scholar     ","['https://doi.org/10.1212/01.WNL.0000147469.18313.3B', 'https://scholar.google.com/scholar_lookup?title=MCI+conversion+to+dementia+and+APOE+genotype:+a+prediction+study+with+FDG‐PET&author=L+Mosconi&author=D+Perani&author=S+Sorbi&author=K+Herholz&author=B+Nacmias&author=V+Holthoff&publication_year=2004&hl=en']",,https://doi.org/10.1212/01.WNL.0000147469.18313.3B, Mosconi 2004 {published data only}  ,included,CD010632-bbs2-0011,
CD010632-bib-0012,"Nobili F, Salmaso D, Morbelli S, Girtler N, Piccardo A, Brugnolo A, et al. ",Principal component analysis of FDG PET in amnestic MCI, European Journal of Nuclear Medicine and Molecular Imaging ,2008,35,    ,['citation-journal']," Nobili F, Salmaso D, Morbelli S, Girtler N, Piccardo A, Brugnolo A, et al. Principal component analysis of FDG PET in amnestic MCI.  European Journal of Nuclear Medicine and Molecular Imaging 2008;35(12):2191‐202.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-008-0869-z', 'https://scholar.google.com/scholar_lookup?title=Principal+component+analysis+of+FDG+PET+in+amnestic+MCI&author=F+Nobili&author=D+Salmaso&author=S+Morbelli&author=N+Girtler&author=A+Piccardo&author=A+Brugnolo&publication_year=2008&hl=en']",,https://doi.org/10.1007/s00259-008-0869-z, Nobili 2008 {published data only}  ,included,CD010632-bbs2-0012,
CD010632-bib-0013,"Ossenkoppele R, Tolboom N, Foster‐Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, et al. ","Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET", European Journal of Nuclear Medicine and Molecular Imaging ,2012,39,    ,['citation-journal']," Ossenkoppele R, Tolboom N, Foster‐Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, et al. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.  European Journal of Nuclear Medicine and Molecular Imaging 2012;39(6):990‐1000.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-012-2102-3', 'https://scholar.google.com/scholar_lookup?title=Longitudinal+imaging+of+Alzheimer+pathology+using+[11C]PIB,+[18F]FDDNP+and+[18F]FDG+PET+&author=R+Ossenkoppele&author=N+Tolboom&author=JC+Foster‐Dingley&author=SF+Adriaanse&author=R+Boellaard&author=M+Yaqub&publication_year=2012&hl=en']",,https://doi.org/10.1007/s00259-012-2102-3, Ossenkoppele 2012a {published data only}  ,included,CD010632-bbs2-0013,
CD010632-bib-0014,"Ossenkoppele R, Prins N, Pijnenburg YAL, Lemstra AW, Van der Flier WM, Adriaanse SF, et al. ",Impact of molecular imaging on the diagnostic process in a memory clinic, Alzheimer's & Dementia ,2012,9,    ,['citation-journal']," Ossenkoppele R, Prins N, Pijnenburg YAL, Lemstra AW, Van der Flier WM, Adriaanse SF, et al. Impact of molecular imaging on the diagnostic process in a memory clinic.  Alzheimer's & Dementia 2012;9(4):414‐21.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jalz.2012.07.003', 'https://scholar.google.com/scholar_lookup?title=Impact+of+molecular+imaging+on+the+diagnostic+process+in+a+memory+clinic&author=R+Ossenkoppele&author=N+Prins&author=YAL+Pijnenburg&author=AW+Lemstra&author=WM+Flier&author=SF+Adriaanse&publication_year=2012&hl=en']",,https://doi.org/10.1016/j.jalz.2012.07.003, Ossenkoppele 2012b {published data only}  ,included,CD010632-bbs2-0014,
CD010632-bib-0015,"Pardo JV, Lee JT, Kuskowski MA, Munch KR, Carlis JV, Sheikh SA, et al. ",Fluorodeoxiglucose positron emission tomography of mild cognitive impairment with clinical follow‐up at 3 years, Alzheimer's & Dementia ,2010,6,    ,['citation-journal']," Pardo JV, Lee JT, Kuskowski MA, Munch KR, Carlis JV, Sheikh SA, et al. Fluorodeoxiglucose positron emission tomography of mild cognitive impairment with clinical follow‐up at 3 years.  Alzheimer's & Dementia 2010;6(4):326‐33.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jalz.2009.09.005', 'https://scholar.google.com/scholar_lookup?title=Fluorodeoxiglucose+positron+emission+tomography+of+mild+cognitive+impairment+with+clinical+follow‐up+at+3+years+&author=JV+Pardo&author=JT+Lee&author=MA+Kuskowski&author=KR+Munch&author=JV+Carlis&author=SA+Sheikh&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.jalz.2009.09.005, Pardo 2010 {published data only}  ,included,CD010632-bbs2-0015,
CD010632-bib-0016,"Schmand B, Eikelenboom P, van Gool WA, Alzheimer's Disease Neuroimaging Initiative. ",Value of diagnostic tests to predict conversion to Alzheimer’s Disease in young and old patients with amnestic mild cognitive impairment, Journal of Alzheimer's Disease ,2012,29,    ,['citation-journal']," Schmand B, Eikelenboom P, van Gool WA, Alzheimer's Disease Neuroimaging Initiative. Value of diagnostic tests to predict conversion to Alzheimer’s Disease in young and old patients with amnestic mild cognitive impairment.  Journal of Alzheimer's Disease 2012;29(3):641‐8.    Link to article     Google Scholar     ","['https://doi.org/10.3233/JAD-2012-111703', 'https://scholar.google.com/scholar_lookup?title=Value+of+diagnostic+tests+to+predict+conversion+to+Alzheimer’s+Disease+in+young+and+old+patients+with+amnestic+mild+cognitive+impairment+&author=B+Schmand&author=P+Eikelenboom&author=WA+Gool&publication_year=2012&hl=en']",,https://doi.org/10.3233/JAD-2012-111703, Schmand 2012 {published data only}  ,included,CD010632-bbs2-0016,
CD010632-bib-0017,"Bastin C, Kerrouche N, Lekeu F, Adam S, Guillame B, Lemaire C, et al. ",Controlled memory processes in questionable Alzheimer's disease: A view from neuroimaging research,,2010,,    ,['citation-other']," Bastin C, Kerrouche N, Lekeu F, Adam S, Guillame B, Lemaire C, et al. Controlled memory processes in questionable Alzheimer's disease: A view from neuroimaging research. Journal of Alzheimer's Disease2010; Vol. 20, issue 2:547‐60.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Controlled+memory+processes+in+questionable+Alzheimer's+disease:+A+view+from+neuroimaging+research+&author=C+Bastin&author=N+Kerrouche&author=F+Lekeu&author=S+Adam&author=B+Guillame&author=C+Lemaire&publication_year=2010&hl=en""]",,, Bastin 2010 {published data only}  ,excluded,CD010632-bbs2-0017, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators.  Study design: threshold not used (Author's email on 14th August 2012) 
CD010632-bib-0018,"Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, et al. ",The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes,,2010,,    ,['citation-other']," Beckett LA, Harvey DJ, Gamst A, Donohue M, Kornak J, Zhang H, et al. The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes. Alzheimer's & Dementia2010; Vol. 6, issue 3:257‐64. [1552‐5260]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=The+Alzheimer's+Disease+Neuroimaging+Initiative:+Annual+change+in+biomarkers+and+clinical+outcomes+&author=LA+Beckett&author=DJ+Harvey&author=A+Gamst&author=M+Donohue&author=J+Kornak&author=H+Zhang&publication_year=2010&hl=en""]",,, Beckett 2010 {published data only}  ,excluded,CD010632-bbs2-0018, Study design: threshold not used. The focus of the study was to compare annual changes in rCMRglc levels between MCI converters and MCI non‐converters at follow‐up (ADNI study).  
CD010632-bib-0019,"Charil A, Carbonell F, Reilhac A, Deduck K, Sood R, Evans A. ",Changes in MRI cortical thickness and [18F]FDG PET data over 24 months in subjects from the Alzheimer's disease neuroimaging initiative (ADNI) study,,2011,,    ,['citation-other']," Charil A, Carbonell F, Reilhac A, Deduck K, Sood R, Evans A. Changes in MRI cortical thickness and [18F]FDG PET data over 24 months in subjects from the Alzheimer's disease neuroimaging initiative (ADNI) study. Alzheimer's and Dementia Conference: Alzheimer's Association International Conference, AAIC 11 Paris France. Conference Publication. 2011.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Changes+in+MRI+cortical+thickness+and+[18F]FDG+PET+data+over+24+months+in+subjects+from+the+Alzheimer's+disease+neuroimaging+initiative+(ADNI)+study+&author=A+Charil&author=F+Carbonell&author=A+Reilhac&author=K+Deduck&author=R+Sood&author=A+Evans&publication_year=2011&hl=en""]",,, Charil 2011 {published data only}  ,excluded,CD010632-bbs2-0019, Study design: threshold not used. The focus of the study was to investigate annual changes in FDG‐PET scans in different study groups (ADNI study).  
CD010632-bib-0020,"Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, et al. ",Twelve‐month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre‐defined statistical region‐of‐interest: findings from the Alzheimer's Disease Neuroimaging Initiative,,2010,,    ,['citation-other']," Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, et al. Twelve‐month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre‐defined statistical region‐of‐interest: findings from the Alzheimer's Disease Neuroimaging Initiative. NeuroImage2010; Vol. 51, issue 2:654‐64. [1053‐8119]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Twelve‐month+metabolic+declines+in+probable+Alzheimer's+disease+and+amnestic+mild+cognitive+impairment+assessed+using+an+empirically+pre‐defined+statistical+region‐of‐interest:+findings+from+the+Alzheimer's+Disease+Neuroimaging+Initiative+&author=K+Chen&author=JB+Langbaum&author=AS+Fleisher&author=N+Ayutyanont&author=C+Reschke&author=W+Lee&publication_year=2010&hl=en""]",,, Chen 2010 {published data only}  ,excluded,CD010632-bbs2-0020, Target condition: not conversion from MCI to dementia. Study design: threshold not used. The focus of the study was the measurement of the cerebral metabolic rate for glucose over a 12‐month period (ADNI study).  
CD010632-bib-0021,"Chételat G, Desgranges B, De la Sayette V, Lalevee C, Landeau B, Dupuy B. ",Metabolic profile of patients with mild cognitive impairment (MCI) destined to convert to Alzheimer's disease (AD), Society for Neuroscience Abstracts ,2001,27,    ,['citation-journal']," Chételat G, Desgranges B, De la Sayette V, Lalevee C, Landeau B, Dupuy B. Metabolic profile of patients with mild cognitive impairment (MCI) destined to convert to Alzheimer's disease (AD).  Society for Neuroscience Abstracts 2001;27(1):196.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Metabolic+profile+of+patients+with+mild+cognitive+impairment+(MCI)+destined+to+convert+to+Alzheimer's+disease+(AD)+&author=G+Chételat&author=B+Desgranges&author=V+Sayette&author=C+Lalevee&author=B+Landeau&author=B+Dupuy&publication_year=2001&hl=en""]",,, Chételat 2001 {published data only}  ,excluded,CD010632-bbs2-0021, Study design: threshold not used. The focus of the study was to statistically compare initial PET data of people who developed ADD to those who did not at follow‐up.  
CD010632-bib-0022,"Chételat G, Eustache F, Viader F, De la Sayette V, Pélerin A, Mézenge F, et al. ",FDG‐PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment,,2005,,    ,['citation-other']," Chételat G, Eustache F, Viader F, De la Sayette V, Pélerin A, Mézenge F, et al. FDG‐PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase2005; Vol. 11, issue 1:14‐25.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=FDG‐PET+measurement+is+more+accurate+than+neuropsychological+assessments+to+predict+global+cognitive+deterioration+in+patients+with+mild+cognitive+impairment+&author=G+Chételat&author=F+Eustache&author=F+Viader&author=V+Sayette&author=A+Pélerin&author=F+Mézenge&publication_year=2005&hl=en'],,, Chételat 2005 {published data only}  ,excluded,CD010632-bbs2-0022, Target condition: not conversion from MCI to dementia. Study design: threshold not used. The focus of the study was the measurement of the cerebral metabolic rate for glucose and comparison between that measurement and neuropsychological assessment in predicting global cognitive deterioration in people with MCI over an 18‐month period.  
CD010632-bib-0023,"Desikan RS, Cabral HJ, Settecase F, Hess CP, Dillon WP, Glastonbury CM, et al. ",Automated MRI measures predict progression to Alzheimer's disease,,2010,,    ,['citation-other']," Desikan RS, Cabral HJ, Settecase F, Hess CP, Dillon WP, Glastonbury CM, et al. Automated MRI measures predict progression to Alzheimer's disease. Neurobiology of Aging2010; Vol. 31, issue 8:1364‐74.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Automated+MRI+measures+predict+progression+to+Alzheimer's+disease&author=RS+Desikan&author=HJ+Cabral&author=F+Settecase&author=CP+Hess&author=WP+Dillon&author=CM+Glastonbury&publication_year=2010&hl=en""]",,, Desikan 2010 {published data only}  ,excluded,CD010632-bbs2-0023, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  Study design: threshold not used (ADNI study). 
CD010632-bib-0024,"Drzezga A, Lautenschlager N, Siebner H, Reimenschneider M, Willoch F, Minoshima S, et al. ",Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow‐up study, European Journal of Nuclear Medicine and Molecular Imaging ,2003,30,    ,['citation-journal']," Drzezga A, Lautenschlager N, Siebner H, Reimenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow‐up study.  European Journal of Nuclear Medicine and Molecular Imaging 2003;30(8):1104‐13.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Cerebral+metabolic+changes+accompanying+conversion+of+mild+cognitive+impairment+into+Alzheimer's+disease:+a+PET+follow‐up+study+&author=A+Drzezga&author=N+Lautenschlager&author=H+Siebner&author=M+Reimenschneider&author=F+Willoch&author=S+Minoshima&publication_year=2003&hl=en""]",,, Drzezga 2003 {published data only}  ,excluded,CD010632-bbs2-0024, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  Study design: threshold not used. The focus of the study was to evaluate changes in the baseline and follow‐up ¹⁸F‐FDG‐PET scans.  
CD010632-bib-0025,"Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. ",PET imaging of amyloid deposition in patients with mild cognitive impairment,,2008,,    ,['citation-other']," Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiology of Aging2008; Vol. 29, issue 10:1456‐65.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=PET+imaging+of+amyloid+deposition+in+patients+with+mild+cognitive+impairment&author=A+Forsberg&author=H+Engler&author=O+Almkvist&author=G+Blomquist&author=G+Hagman&author=A+Wall&publication_year=2008&hl=en'],,, Forsberg 2008 {published data only}  ,excluded,CD010632-bbs2-0025, Study design: threshold not used. The focus of the study was to compare rCMRglc levels between MCI converters and MCI non‐converters at follow‐up.  
CD010632-bib-0026,"Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, et al. ",Education and occupation as proxies for reserve in aMCI converters and AD FDG‐PET evidence, Neurology ,2008,71,    ,['citation-journal']," Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, et al. Education and occupation as proxies for reserve in aMCI converters and AD FDG‐PET evidence.  Neurology 2008;71(17):1342‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1212/01.wnl.0000327670.62378.c0', 'https://scholar.google.com/scholar_lookup?title=Education+and+occupation+as+proxies+for+reserve+in+aMCI+converters+and+AD+FDG‐PET+evidence+&author=V+Garibotto&author=B+Borroni&author=E+Kalbe&author=K+Herholz&author=E+Salmon&author=V+Holtoff&publication_year=2008&hl=en']",,https://doi.org/10.1212/01.wnl.0000327670.62378.c0, Garibotto 2008 {published data only}  ,excluded,CD010632-bbs2-0026, Study design: threshold not used. The focus of the study was to assess education and occupation as proxies for reserve in aMCI converters.  
CD010632-bib-0027,"Gray KR, Wolz R, Heckemann RA, Aljabar P, Hammers A, Rueckert D. ",Multi‐region analysis of longitudinal FDG‐PET for the classification of Alzheimer's disease, NeuroImage ,2012,60,    ,['citation-journal']," Gray KR, Wolz R, Heckemann RA, Aljabar P, Hammers A, Rueckert D. Multi‐region analysis of longitudinal FDG‐PET for the classification of Alzheimer's disease.  NeuroImage 2012;60(1):221‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.neuroimage.2011.12.071', ""https://scholar.google.com/scholar_lookup?title=Multi‐region+analysis+of+longitudinal+FDG‐PET+for+the+classification+of+Alzheimer's+disease+&author=KR+Gray&author=R+Wolz&author=RA+Heckemann&author=P+Aljabar&author=A+Hammers&author=D+Rueckert&publication_year=2012&hl=en""]",,https://doi.org/10.1016/j.neuroimage.2011.12.071, Gray 2012 {published data only}  ,excluded,CD010632-bbs2-0027, Study design: threshold not used. The focus of the study was to investigate the value of combining cross‐sectional and longitudinal multi‐region FDG‐PET information for classification of Alzheimer's disease (ADNI study).  
CD010632-bib-0028,"Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J. ",Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease, Psychiatry Research ,2007,155,    ,['citation-journal']," Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.  Psychiatry Research 2007;155(2):147‐54.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.pscychresns.2006.12.003', ""https://scholar.google.com/scholar_lookup?title=Reduced+cerebral+glucose+metabolism+in+patients+at+risk+for+Alzheimer's+disease&author=A+Hunt&author=P+Schönknecht&author=M+Henze&author=U+Seidl&author=U+Haberkorn&author=J+Schröder&publication_year=2007&hl=en""]",,https://doi.org/10.1016/j.pscychresns.2006.12.003, Hunt 2007 {published data only}  ,excluded,CD010632-bbs2-0028, Study design: threshold not used. The focus of the study was to compare rCMRglc levels between MCI converters and MCI non‐converters at follow‐up.  
CD010632-bib-0029,"Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S. ",Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki‐Tajiri Project, International Psychogeriatrics ,2009,21,    ,['citation-journal']," Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki‐Tajiri Project.  International Psychogeriatrics 2009;21(1):148‐56.    Link to article     Google Scholar     ","['https://doi.org/10.1017/S1041610208008132', ""https://scholar.google.com/scholar_lookup?title=Decreased+cortical+glucose+metabolism+in+converters+from+CDR+0.5+to+Alzheimer's+disease+in+a+community:+the+Osaki‐Tajiri+Project+&author=H+Ishii&author=H+Ishikawa&author=K+Meguro&author=M+Tashiro&author=S+Yamaguchi&publication_year=2009&hl=en""]",,https://doi.org/10.1017/S1041610208008132, Ishii 2009 {published data only}  ,excluded,CD010632-bbs2-0029, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  Study design: threshold not used. The focus of the study was to compare rCMRglc levels between MCI converters and MCI non‐converters at follow‐up.  
CD010632-bib-0030,"Ishii K, Ito K, Senda M, Kato T, Fukuyama H, Ouchi Y, Meguro K, et al. SEAD‐J Group. ",FDG‐PET and automatic diagnosis systems for prediction of conversion to Alzheimer disease in subjects with mild cognitive impairments: Study on diagnosis of early Alzheimer disease‐Japan (SEAD‐J),,2011,,    ,['citation-other']," Ishii K, Ito K, Senda M, Kato T, Fukuyama H, Ouchi Y, Meguro K, et al. SEAD‐J Group. FDG‐PET and automatic diagnosis systems for prediction of conversion to Alzheimer disease in subjects with mild cognitive impairments: Study on diagnosis of early Alzheimer disease‐Japan (SEAD‐J). Annual Congress of the European Association of Nuclear Medicine, Birmingham. Conference Publication. 2011.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=FDG‐PET+and+automatic+diagnosis+systems+for+prediction+of+conversion+to+Alzheimer+disease+in+subjects+with+mild+cognitive+impairments:+Study+on+diagnosis+of+early+Alzheimer+disease‐Japan+(SEAD‐J)+&author=K+Ishii&author=K+Ito&author=M+Senda&author=T+Kato&author=H+Fukuyama&author=Y+Ouchi&author=K+Meguro&publication_year=2011&hl=en'],,, Ishii 2011 {published data only}  ,excluded,CD010632-bbs2-0030, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  
CD010632-bib-0031,"Jagust W, Reed B, Mungas D, Ellis W, Decarli C. ",What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?, Neurology ,2007,69,    ,['citation-journal']," Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?.  Neurology 2007;69(9):871‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1212/01.wnl.0000269790.05105.16', 'https://scholar.google.com/scholar_lookup?title=What+does+fluorodeoxyglucose+PET+imaging+add+to+a+clinical+diagnosis+of+dementia?&author=W+Jagust&author=B+Reed&author=D+Mungas&author=W+Ellis&author=C+Decarli&publication_year=2007&hl=en']",,https://doi.org/10.1212/01.wnl.0000269790.05105.16, Jagust 2007 {published data only}  ,excluded,CD010632-bbs2-0031, Target condition: not conversion from MCI to dementia. Study design: threshold not used. 
CD010632-bib-0032,"Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Langstrom B, Nordberg A. ",Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease, Neurobiology of Aging ,2012,33,    ,['citation-journal']," Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Langstrom B, Nordberg A. Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.  Neurobiology of Aging 2012;33(1):198.e1‐14.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.neurobiolaging.2010.06.015', ""https://scholar.google.com/scholar_lookup?title=Dynamic+changes+in+PET+amyloid+and+FDG+imaging+at+different+stages+of+Alzheimer's+disease+&author=A+Kadir&author=O+Almkvist&author=A+Forsberg&author=A+Wall&author=H+Engler&author=B+Langstrom&author=A+Nordberg&publication_year=2012&hl=en""]",,https://doi.org/10.1016/j.neurobiolaging.2010.06.015, Kadir 2012 {published data only}  ,excluded,CD010632-bbs2-0032, Study design: threshold not used. The focus of the study was to examine dynamic changes in FDG imaging at different stages of Alzheimer's disease.  
CD010632-bib-0033,"Kawashima S, Ito K, Kato T, SEAD‐J Study Group. ",Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies, BMJ Open ,2012,2,    ,['citation-journal']," Kawashima S, Ito K, Kato T, SEAD‐J Study Group. Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies.  BMJ Open 2012;2(2):e000773.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmjopen-2011-000773', 'https://scholar.google.com/scholar_lookup?title=Inclusion+criteria+provide+heterogeneity+in+baseline+profiles+of+patients+with+mild+cognitive+impairment:+comparison+of+two+prospective+cohort+studies+&author=S+Kawashima&author=K+Ito&author=T+Kato&publication_year=2012&hl=en']",,https://doi.org/10.1136/bmjopen-2011-000773, Kawashima 2012 {published data only}  ,excluded,CD010632-bbs2-0033, Study design: threshold not used. The focus of the study was to examine the association between baseline profiles and risk of early conversion to ADD (ADNI study).  
CD010632-bib-0034,"Kim SK, Seo SW, Yoon DS, Chin J, Lee BH, Cheong HK, et al. ",Comparison of neuropsychological and FDG‐PET findings between early‐ versus late‐onset mild cognitive impairment: A five‐year longitudinal study, Dementia and Geriatric Cognitive Disorders ,2010,29,    ,['citation-journal']," Kim SK, Seo SW, Yoon DS, Chin J, Lee BH, Cheong HK, et al. Comparison of neuropsychological and FDG‐PET findings between early‐ versus late‐onset mild cognitive impairment: A five‐year longitudinal study.  Dementia and Geriatric Cognitive Disorders 2010;29(3):213‐23.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000278422', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+neuropsychological+and+FDG‐PET+findings+between+early‐+versus+late‐onset+mild+cognitive+impairment:+A+five‐year+longitudinal+study+&author=SK+Kim&author=SW+Seo&author=DS+Yoon&author=J+Chin&author=BH+Lee&author=HK+Cheong&publication_year=2010&hl=en']",,https://doi.org/10.1159/000278422, Kim 2010 {published data only}  ,excluded,CD010632-bbs2-0034, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators.  Study design: threshold not used (Author's email on 4th October 2013) 
CD010632-bib-0035,"Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, the Alzheimer's Disease Neuroimaging Initiative. ","Associations between cognitive, functional, and FDG‐PET measures of decline in AD and MC", Neurobiology of Aging ,2011,32,    ,['citation-journal']," Landau SM, Harvey D, Madison CM, Koeppe RA, Reiman EM, Foster NL, Weiner MW, Jagust WJ, the Alzheimer's Disease Neuroimaging Initiative. Associations between cognitive, functional, and FDG‐PET measures of decline in AD and MC.  Neurobiology of Aging 2011;32(7):1207‐18.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.neurobiolaging.2009.07.002', 'https://scholar.google.com/scholar_lookup?title=Associations+between+cognitive,+functional,+and+FDG‐PET+measures+of+decline+in+AD+and+MC+&author=SM+Landau&author=D+Harvey&author=CM+Madison&author=RA+Koeppe&author=EM+Reiman&author=NL+Foster&author=MW+Weiner&author=WJ+Jagust&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.neurobiolaging.2009.07.002, Landau 2011 {published data only}  ,excluded,CD010632-bbs2-0035, Study design: threshold not used. The focus of the study was to assess annual changes in biomarkers (ADNI study).  
CD010632-bib-0036,"Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, at al, Alzheimer's Disease Neuroimaging Initiative. ","Amyloid deposition, hypometabolism, and longitudinal cognitive decline", Annals of Neurology ,2012,72,    ,['citation-journal']," Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, at al, Alzheimer's Disease Neuroimaging Initiative. Amyloid deposition, hypometabolism, and longitudinal cognitive decline.  Annals of Neurology 2012;72(4):578‐86.    Link to article     Google Scholar     ","['https://doi.org/10.1002/ana.23650', 'https://scholar.google.com/scholar_lookup?title=Amyloid+deposition,+hypometabolism,+and+longitudinal+cognitive+decline&author=SM+Landau&author=MA+Mintun&author=AD+Joshi&author=RA+Koeppe&author=RC+Petersen&author=PS+Aisen&author=al+at&publication_year=2012&hl=en']",,https://doi.org/10.1002/ana.23650, Landau 2012 {published data only}  ,excluded,CD010632-bbs2-0036, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared  
CD010632-bib-0037,"Lee DY, Choo LLH, Seo EH, Sohn BK, Park JH, Kim JW, et al. ",Combination of cerebral metabolic and cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two‐year follow‐up study, Alzheimer's & Dementia ,2011,7,    ,['citation-journal']," Lee DY, Choo LLH, Seo EH, Sohn BK, Park JH, Kim JW, et al. Combination of cerebral metabolic and cognitive information as a better predictor of the conversion to Alzheimer's disease in mild cognitive impairment: A two‐year follow‐up study.  Alzheimer's & Dementia 2011;7(4 Supplement):S29.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Combination+of+cerebral+metabolic+and+cognitive+information+as+a+better+predictor+of+the+conversion+to+Alzheimer's+disease+in+mild+cognitive+impairment:+A+two‐year+follow‐up+study+&author=DY+Lee&author=LLH+Choo&author=EH+Seo&author=BK+Sohn&author=JH+Park&author=JW+Kim&publication_year=2011&hl=en""]",,, Lee 2011 {published data only}  ,excluded,CD010632-bbs2-0037, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  
CD010632-bib-0038,"Lo RY, Hubbard AlE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS. ",Longitudinal change of biomarkers in cognitive decline, Archives of Neurology ,2011,68,    ,['citation-journal']," Lo RY, Hubbard AlE, Shaw LM, Trojanowski JQ, Petersen RC, Aisen PS. Longitudinal change of biomarkers in cognitive decline.  Archives of Neurology 2011;68(10):1257‐66.    Link to article     Google Scholar     ","['https://doi.org/10.1001/archneurol.2011.123', 'https://scholar.google.com/scholar_lookup?title=Longitudinal+change+of+biomarkers+in+cognitive+decline&author=RY+Lo&author=AlE+Hubbard&author=LM+Shaw&author=JQ+Trojanowski&author=RC+Petersen&author=PS+Aisen&publication_year=2011&hl=en']",,https://doi.org/10.1001/archneurol.2011.123, Lo 2011 {published data only}  ,excluded,CD010632-bbs2-0038, Target condition: not conversion from MCI to dementia. Study design: threshold not used. The focus of the study was to investigate rates of change in level of FDG uptake (ADNI study)..  
CD010632-bib-0039,"Lo RY, Jagust W. ",Vascular burden and Alzheimer disease pathologic progression, Neurology ,2012,79,    ,['citation-journal']," Lo RY, Jagust W. Vascular burden and Alzheimer disease pathologic progression.  Neurology 2012;79(13):1349‐55.    Link to article     Google Scholar     ","['https://doi.org/10.1212/WNL.0b013e31826c1b9d', 'https://scholar.google.com/scholar_lookup?title=Vascular+burden+and+Alzheimer+disease+pathologic+progression&author=RY+Lo&author=W+Jagust&publication_year=2012&hl=en']",,https://doi.org/10.1212/WNL.0b013e31826c1b9d, Lo 2012 {published data only}  ,excluded,CD010632-bbs2-0039, Target condition: not conversion from MCI to dementia. Study design: threshold not used. The focus of the study was to investigate the vascular contribution to longitudinal changes of rCMRglc in MCI and ADD participants (ADNI study).  
CD010632-bib-0040,"Lorenzi M, Donohue M, Paternico D, Scarpazza C, Ostrowictzki S, Blin O, et al. ",Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment, Neurobiology ,2010,31,    ,['citation-journal']," Lorenzi M, Donohue M, Paternico D, Scarpazza C, Ostrowictzki S, Blin O, et al. Enrichment through biomarkers in clinical trials of Alzheimer's drugs in patients with mild cognitive impairment.  Neurobiology 2010;31(8):1443‐51.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Enrichment+through+biomarkers+in+clinical+trials+of+Alzheimer's+drugs+in+patients+with+mild+cognitive+impairment+&author=M+Lorenzi&author=M+Donohue&author=D+Paternico&author=C+Scarpazza&author=S+Ostrowictzki&author=O+Blin&publication_year=2010&hl=en""]",,, Lorenzi 2010 {published data only}  ,excluded,CD010632-bbs2-0040, Target condition: not conversion from MCI to dementia. Study design: threshold not used. The focus of the study was to assess the benefit of the enrichment of MCI participants with true Alzheimer's disease cases by means of ¹⁸F‐FDG‐PET scan and other biomarkers (ADNI study).  
CD010632-bib-0041,"Lucidi G, Marini S, Nacmias B, Berti V, Bessi V, Bracco L et al . Journal of Alzheimer's Disease Conference: 7th Congresso Sindem: Italian Association for the Study of Dementia Linked to the Italian Neurological Society, SIN Naples Italy. ",Multidisciplinary approach to MCI help to evaluate risk of conversion in AD,,2012,,    ,['citation-other']," Lucidi G, Marini S, Nacmias B, Berti V, Bessi V, Bracco L et al . Journal of Alzheimer's Disease Conference: 7th Congresso Sindem: Italian Association for the Study of Dementia Linked to the Italian Neurological Society, SIN Naples Italy. Multidisciplinary approach to MCI help to evaluate risk of conversion in AD. Journal of Alzheimer's Disease Conference: 7th Congresso Sindem: Italian Association for the Study of Dementia Linked to the Italian Neurological Society, SIN Naples Italy. 2012:(var.pagings).    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Multidisciplinary+approach+to+MCI+help+to+evaluate+risk+of+conversion+in+AD&author=G+Lucidi&author=S+Marini&author=B+Nacmias&author=V+Berti&author=V+Bessi&author=Italy+SINNaples&publication_year=2012&hl=en'],,, Lucidi 2012 {published data only}  ,excluded,CD010632-bbs2-0041, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  
CD010632-bib-0042,"Morbelli S, Piccardo A, Villavecchia G, Dessi B, Brugnolo A, Piccini A, et al. ",Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel‐based MRI and FDG‐PET study, European Journal of Nuclear Medicine and Molecular Imaging ,2010,37,    ,['citation-journal']," Morbelli S, Piccardo A, Villavecchia G, Dessi B, Brugnolo A, Piccini A, et al. Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel‐based MRI and FDG‐PET study.  European Journal of Nuclear Medicine and Molecular Imaging 2010;37(1):36‐45. [1619‐7070]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-009-1218-6', 'https://scholar.google.com/scholar_lookup?title=Mapping+brain+morphological+and+functional+conversion+patterns+in+amnestic+MCI:+a+voxel‐based+MRI+and+FDG‐PET+study+&author=S+Morbelli&author=A+Piccardo&author=G+Villavecchia&author=B+Dessi&author=A+Brugnolo&author=A+Piccini&publication_year=2010&hl=en']",,https://doi.org/10.1007/s00259-009-1218-6, Morbelli 2010 {published data only}  ,excluded,CD010632-bbs2-0042, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  Study design: threshold not used. The focus of the study was to concurrently investigate patterns of hypometabolism and athrophy in people with aMCI converted to ADD.  
CD010632-bib-0043,"Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, Van Berckel BNM, et al. ",Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project, Neurobiology of Aging ,2012,33,    ,['citation-journal']," Morbelli S, Drzezga A, Perneczky R, Frisoni GB, Caroli A, Van Berckel BNM, et al. Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.  Neurobiology of Aging 2012;33(11):2533‐50.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.neurobiolaging.2012.01.005', ""https://scholar.google.com/scholar_lookup?title=Resting+metabolic+connectivity+in+prodromal+Alzheimer's+disease.+A+European+Alzheimer+Disease+Consortium+(EADC)+project+&author=S+Morbelli&author=A+Drzezga&author=R+Perneczky&author=GB+Frisoni&author=A+Caroli&author=BNM+Berckel&publication_year=2012&hl=en""]",,https://doi.org/10.1016/j.neurobiolaging.2012.01.005, Morbelli 2012 {published data only}  ,excluded,CD010632-bbs2-0043, Study design: threshold not used. The focus of the study was to explore resting‐state metabolic connectivity in people with aMCI who converted to ADD at follow‐up.  
CD010632-bib-0044,"Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A. ",MCI patients declining and not‐declining at mid‐term follow‐up: FDG‐PET findings, Current Alzheimer Research ,2010,7,    ,['citation-journal']," Pagani M, Dessi B, Morbelli S, Brugnolo A, Salmaso D, Piccini A. MCI patients declining and not‐declining at mid‐term follow‐up: FDG‐PET findings.  Current Alzheimer Research 2010;7(4):287‐94.    Link to article     Google Scholar     ","['https://doi.org/10.2174/156720510791162368', 'https://scholar.google.com/scholar_lookup?title=MCI+patients+declining+and+not‐declining+at+mid‐term+follow‐up:+FDG‐PET+findings&author=M+Pagani&author=B+Dessi&author=S+Morbelli&author=A+Brugnolo&author=D+Salmaso&author=A+Piccini&publication_year=2010&hl=en']",,https://doi.org/10.2174/156720510791162368, Pagani 2010 {published data only}  ,excluded,CD010632-bbs2-0044, Study design: threshold not used. The focus of the study was to test the hypothesis that the combination of memory and brain metabolic assessment could identify subgroups of those MCI who would convert or would not convert to dementia at follow‐up.  
CD010632-bib-0045,"Small GW, La Rue A, Komo S, Kaplan A, Mandelkern MA. ",Predictors of cognitive change in middle‐aged and older adults with memory loss, American Journal of Psychiatry ,1995,152,    ,['citation-journal']," Small GW, La Rue A, Komo S, Kaplan A, Mandelkern MA. Predictors of cognitive change in middle‐aged and older adults with memory loss.  American Journal of Psychiatry 1995;152(12):1757‐64.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Predictors+of+cognitive+change+in+middle‐aged+and+older+adults+with+memory+loss&author=GW+Small&author=A+Rue&author=S+Komo&author=A+Kaplan&author=MA+Mandelkern&publication_year=1995&hl=en'],,, Small 1995 {published data only}  ,excluded,CD010632-bbs2-0045, Study design: threshold not used. The focus of the study was to investigate predictors of cognitive changes in middle‐aged and older adults with memory loss.  
CD010632-bib-0046,"Torosyan N, Mason K, Dahlbom M, Silverman DH. ","Predictive value of FDG‐PET scans for conversion from mild cognitive impairment to dementia by subjects participating in the Alzheimer’s Disease Neuroimaging Initiative study, using a metabolic index generated with clinically routine software",,2011,,    ,['citation-other']," Torosyan N, Mason K, Dahlbom M, Silverman DH. Predictive value of FDG‐PET scans for conversion from mild cognitive impairment to dementia by subjects participating in the Alzheimer’s Disease Neuroimaging Initiative study, using a metabolic index generated with clinically routine software. Molecular Imaging and Biology Conference: 2011 World Molecular Imaging Congres, San Diego, CA United States. Conference Publication. 2011.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Predictive+value+of+FDG‐PET+scans+for+conversion+from+mild+cognitive+impairment+to+dementia+by+subjects+participating+in+the+Alzheimer’s+Disease+Neuroimaging+Initiative+study,+using+a+metabolic+index+generated+with+clinically+routine+software+&author=N+Torosyan&author=K+Mason&author=M+Dahlbom&author=DH+Silverman&publication_year=2011&hl=en']",,, Torosyan 2011 {published data only}  ,excluded,CD010632-bbs2-0046, Insufficient data to complete 2 x 2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  
CD010632-bib-0047,"Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema‐Notestine C, Hagler DJ, et al. ","Combining MR imaging, positron‐emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease", AJNR: American Journal of Neuroradiology ,2010,31,    ,['citation-journal']," Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema‐Notestine C, Hagler DJ, et al. Combining MR imaging, positron‐emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.  AJNR: American Journal of Neuroradiology 2010;31(2):347‐54.    Link to article     Google Scholar     ","['https://doi.org/10.3174/ajnr.A1809', 'https://scholar.google.com/scholar_lookup?title=Combining+MR+imaging,+positron‐emission+tomography,+and+CSF+biomarkers+in+the+diagnosis+and+prognosis+of+Alzheimer+disease+&author=KB+Walhovd&author=AM+Fjell&author=J+Brewer&author=LK+McEvoy&author=C+Fennema‐Notestine&author=DJ+Hagler&publication_year=2010&hl=en']",,https://doi.org/10.3174/ajnr.A1809, Walhovd 2010 {published data only}  ,excluded,CD010632-bbs2-0047," Study design: threshold not used. The focus of the study was to combine FDG‐PET, MRI and CSF biomarkers in the 2‐year prognosis of MCI and Alzheimer's disease participants (ADNI study).  "
CD010632-bib-0048,"Zhang D, Shen D. ",Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers, PLoS One ,2012,7,    ,['citation-journal']," Zhang D, Shen D. Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers.  PLoS One 2012;7(3):e33182.    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0033182', 'https://scholar.google.com/scholar_lookup?title=Predicting+future+clinical+changes+of+MCI+patients+using+longitudinal+and+multimodal+biomarkers+&author=D+Zhang&author=D+Shen&publication_year=2012&hl=en']",,https://doi.org/10.1371/journal.pone.0033182, Zhang 2012 {published data only}  ,excluded,CD010632-bbs2-0048, Insufficient data to complete 2X2 table. Additional data were requested from the trial investigators but no further information was available at the time this review was prepared.  Study design: threshold not used. The focus of the study was to assess the predictive value of longitudinal and multimodal biomarkers in conversion from MCI to ADD (ADNI study).  
CD010632-bib-0049,"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. ",The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia ,2011,7,    ,['citation-journal']," Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimer's & Dementia 2011;7(3):270‐9. [1552‐5260]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jalz.2011.03.008', ""https://scholar.google.com/scholar_lookup?title=The+diagnosis+of+mild+cognitive+impairment+due+to+Alzheimer’s+disease:+Recommendations+from+the+National+Institute+on+Aging‐Alzheimer’s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer's+disease+&author=MS+Albert&author=ST+DeKosky&author=D+Dickson&author=B+Dubois&author=HH+Feldman&author=NC+Fox&publication_year=2011&hl=en""]",,https://doi.org/10.1016/j.jalz.2011.03.008, Albert 2011 ,additional,CD010632-bbs2-0049,
CD010632-bib-0050,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM‐III‐R),1987,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III‐R). 3rd Edition. Washington DC: American Psychiatric Association, 1987.    ",[],,, APA 1987 ,additional,CD010632-bbs2-0050,
CD010632-bib-0051,American Psychiatric Association. ,,Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR),1994,,.   ,['citation-book']," American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR). 4th Edition. Washington DC: American Psychiatric Association, 1994.    ",[],,, APA 1994 ,additional,CD010632-bbs2-0051,
CD010632-bib-0052,"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. ",Alzheimer's disease, Lancet ,2011,377,    ,['citation-journal']," Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease.  Lancet 2011;377(9770):1019‐31. [PUBMED: 21371747]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(10)61349-9', ""https://scholar.google.com/scholar_lookup?title=Alzheimer's+disease&author=C+Ballard&author=S+Gauthier&author=A+Corbett&author=C+Brayne&author=D+Aarsland&author=E+Jones&publication_year=2011&hl=en""]",21371747,https://doi.org/10.1016/S0140-6736(10)61349-9, Ballard 2011 ,additional,CD010632-bbs2-0052,
CD010632-bib-0053,"Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, et al. ",Quantitative assessment of cerebral blood flow in patients with Alzheimer’s disease by SPECT, Journal of Nuclear Medicine ,1997,38,    ,['citation-journal']," Bartenstein P, Minoshima S, Hirsch C, Buch K, Willoch F, Mösch D, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer’s disease by SPECT.  Journal of Nuclear Medicine 1997;38(7):1095–101.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Quantitative+assessment+of+cerebral+blood+flow+in+patients+with+Alzheimer’s+disease+by+SPECT+&author=P+Bartenstein&author=S+Minoshima&author=C+Hirsch&author=K+Buch&author=F+Willoch&author=D+Mösch&publication_year=1997&hl=en'],,, Bartenstein 1997 ,additional,CD010632-bbs2-0053,
CD010632-bib-0054,"Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, et al. ",European Association of Nuclear Medicine procedure guidelines for brain imaging using [18F]FDG, European Journal of Nuclear Medicine and Molecular Imaging ,2002,29,    ,['citation-journal']," Bartenstein P, Asenbaum S, Catafau A, Halldin C, Pilowski L, Pupi A, et al. European Association of Nuclear Medicine procedure guidelines for brain imaging using [18F]FDG.  European Journal of Nuclear Medicine and Molecular Imaging 2002;29(10):BP43–8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=European+Association+of+Nuclear+Medicine+procedure+guidelines+for+brain+imaging+using+[18F]FDG+&author=P+Bartenstein&author=S+Asenbaum&author=A+Catafau&author=C+Halldin&author=L+Pilowski&author=A+Pupi&publication_year=2002&hl=en'],,, Bartenstein 2002 ,additional,CD010632-bbs2-0054,
CD010632-bib-0055,"Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, et al. ",Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE, Cochrane Database of Systematic Reviews ,2013,,    ,['citation-journal']," Beynon R, Leeflang MM, McDonald S, Eisinga A, Mitchell RL, Whiting P, et al. Search strategies to identify diagnostic accuracy studies in MEDLINE and EMBASE.  Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.MR000022.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.MR000022.pub3', 'https://scholar.google.com/scholar_lookup?title=Search+strategies+to+identify+diagnostic+accuracy+studies+in+MEDLINE+and+EMBASE&author=R+Beynon&author=MM+Leeflang&author=S+McDonald&author=A+Eisinga&author=RL+Mitchell&author=P+Whiting&publication_year=2013&hl=en']",,https://doi.org/10.1002/14651858.MR000022.pub3, Beynon 2013 ,additional,CD010632-bbs2-0055,
CD010632-bib-0056,Birks J. ,Cholinesterase inhibitors for Alzheimer's disease, Cochrane Database of Systematic Reviews ,2006,,    ,['citation-journal']," Birks J. Cholinesterase inhibitors for Alzheimer's disease.  Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005593]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD005593', ""https://scholar.google.com/scholar_lookup?title=Cholinesterase+inhibitors+for+Alzheimer's+disease&author=J+Birks&publication_year=2006&hl=en""]",,https://doi.org/10.1002/14651858.CD005593, Birks 2006 ,additional,CD010632-bbs2-0056,
CD010632-bib-0057,"Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. ",Effectiveness and safety of 18F‐FDG PET in the evaluation of dementia: a review of the recent literature, Journal of Nuclear Medicine ,2012,53,    ,['citation-journal']," Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F‐FDG PET in the evaluation of dementia: a review of the recent literature.  Journal of Nuclear Medicine 2012;53(1):59‐71.    Link to article     Google Scholar     ","['https://doi.org/10.2967/jnumed.111.096578', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+and+safety+of+18F‐FDG+PET+in+the+evaluation+of+dementia:+a+review+of+the+recent+literature+&author=NI+Bohnen&author=DSW+Djang&author=K+Herholz&author=Y+Anzai&author=S+Minoshima&publication_year=2012&hl=en']",,https://doi.org/10.2967/jnumed.111.096578, Bohnen 2012 ,additional,CD010632-bbs2-0057,
CD010632-bib-0058,"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. ",Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative, Family Practice ,2004,21,    ,['citation-journal']," Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.  Family Practice 2004;21(1):4‐10. [0263‐2136]    Link to article     Google Scholar     ","['https://doi.org/10.1093/fampra/cmh103', 'https://scholar.google.com/scholar_lookup?title=Towards+complete+and+accurate+reporting+of+studies+of+diagnostic+accuracy:+the+STARD+initiative+&author=PM+Bossuyt&author=JB+Reitsma&author=DE+Bruns&author=CA+Gatsonis&author=PP+Glasziou&author=LM+Irwig&publication_year=2004&hl=en']",,https://doi.org/10.1093/fampra/cmh103, Bossuyt 2004 ,additional,CD010632-bbs2-0058,
CD010632-bib-0059,"Bossuyt PM, Leeflang MM. ",Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Chapter 6. Version 0.4,,2008,,    ,['citation-other']," Bossuyt PM, Leeflang MM. Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Chapter 6. Version 0.4. srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter06‐Including‐Studies%20%28September‐2008%29.pdf2008.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Developing+criteria+for+including+studies.+Cochrane+Handbook+for+Systematic+Reviews+of+Diagnostic+Test+Accuracy.+Chapter+6.+Version+0.4+&author=PM+Bossuyt&author=MM+Leeflang&publication_year=2008&hl=en'],,, Bossuyt 2008 ,additional,CD010632-bbs2-0059,
CD010632-bib-0060,"Boxer AL, Miller BL. ",Clinical features of frontotemporal dementia,,2005,,    ,['citation-other']," Boxer AL, Miller BL. Clinical features of frontotemporal dementia. Alzheimer Disease and Associated Disorders2005; Vol. 19, issue Suppl 1:S3‐6. [0893‐0341]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Clinical+features+of+frontotemporal+dementia&author=AL+Boxer&author=BL+Miller&publication_year=2005&hl=en'],,, Boxer 2005 ,additional,CD010632-bbs2-0060,
CD010632-bib-0061,"Braak H, Braak E. ",Neuropathological stageing of Alzheimer‐related changes,,1991,,    ,['citation-other']," Braak H, Braak E. Neuropathological stageing of Alzheimer‐related changes. Acta Neuropathologica1991; Vol. 82, issue 4:239‐59. [0001‐6322]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Neuropathological+stageing+of+Alzheimer‐related+changes&author=H+Braak&author=E+Braak&publication_year=1991&hl=en'],,, Braak 1991 ,additional,CD010632-bbs2-0061,
CD010632-bib-0062,"Bruscoli M, Lovestone S. ",Is MCI really just early dementia? A systematic review of conversion studies,,2004,,    ,['citation-other']," Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. International Psychogeriatrics2004; Vol. 16, issue 2:129‐40. [1041‐6102]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Is+MCI+really+just+early+dementia?+A+systematic+review+of+conversion+studies&author=M+Bruscoli&author=S+Lovestone&publication_year=2004&hl=en'],,, Bruscoli 2004 ,additional,CD010632-bbs2-0062,
CD010632-bib-0063,"Brück A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H, et al. ","[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment", European Journal of Nuclear Medicine and Molecular Imaging ,2013,40,    ,['citation-journal']," Brück A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H, et al. [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.  European Journal of Nuclear Medicine and Molecular Imaging 2013;40(10):1567‐72.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-013-2478-8', 'https://scholar.google.com/scholar_lookup?title=[11C]PIB,+[18F]FDG+and+MR+imaging+in+patients+with+mild+cognitive+impairment&author=A+Brück&author=JR+Virta&author=J+Koivunen&author=J+Koikkalainen&author=NM+Scheinin&author=H+Helenius&publication_year=2013&hl=en']",,https://doi.org/10.1007/s00259-013-2478-8, Brück 2013 ,additional,CD010632-bbs2-0063,
CD010632-bib-0064,"Catana C, Drzezga A, Heiss WD, Rosen BR. ",PET/MRI for neurologic applications, Journal of Nuclear Medicine ,2012,53,    ,['citation-journal']," Catana C, Drzezga A, Heiss WD, Rosen BR. PET/MRI for neurologic applications.  Journal of Nuclear Medicine 2012;53(12):1916‐25.    Link to article     Google Scholar     ","['https://doi.org/10.2967/jnumed.112.105346', 'https://scholar.google.com/scholar_lookup?title=PET/MRI+for+neurologic+applications&author=C+Catana&author=A+Drzezga&author=WD+Heiss&author=BR+Rosen&publication_year=2012&hl=en']",,https://doi.org/10.2967/jnumed.112.105346, Catana 2012 ,additional,CD010632-bbs2-0064,
CD010632-bib-0065,"Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. ",Report of a National Institute of Mental Health Work Group: Age associated memory impairment: proposed diagnostic criteria and measures of clinical change, Developmental Neuropsychology ,1986,2,    ,['citation-journal']," Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Report of a National Institute of Mental Health Work Group: Age associated memory impairment: proposed diagnostic criteria and measures of clinical change.  Developmental Neuropsychology 1986;2:261‐76.    Link to article     Google Scholar     ","['https://doi.org/10.1080/87565648609540348', 'https://scholar.google.com/scholar_lookup?title=Report+of+a+National+Institute+of+Mental+Health+Work+Group:+Age+associated+memory+impairment:+proposed+diagnostic+criteria+and+measures+of+clinical+change+&author=T+Crook&author=RT+Bartus&author=SH+Ferris&author=P+Whitehouse&author=GD+Cohen&author=S+Gershon&publication_year=1986&hl=en']",,https://doi.org/10.1080/87565648609540348, Crook 1986 ,additional,CD010632-bbs2-0065,
CD010632-bib-0066,"Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Magiore L, et al. ",Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG‐PET study, European Journal of Nuclear Medicine and Molecular Imaging ,2008,35,    ,['citation-journal']," Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Magiore L, et al. Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild cognitive impairment: an FDG‐PET study.  European Journal of Nuclear Medicine and Molecular Imaging 2008;35(7):1357‐66.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-008-0773-6', 'https://scholar.google.com/scholar_lookup?title=Individual+cerebral+metabolic+deficits+in+Alzheimer’s+disease+and+amnestic+mild+cognitive+impairment:+an+FDG‐PET+study+&author=A+Sole&author=F+Clerici&author=A+Chiti&author=M+Lecchi&author=C+Mariani&author=L+Magiore&publication_year=2008&hl=en']",,https://doi.org/10.1007/s00259-008-0773-6, Del Sole 2008 ,additional,CD010632-bbs2-0066,
CD010632-bib-0067,"Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, et al. ",18F‐FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer‐independent analysis, Journal of Nuclear Medicine ,1999,40,    ,['citation-journal']," Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, et al. 18F‐FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer‐independent analysis.  Journal of Nuclear Medicine 1999;40(5):737–46..    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=18F‐FDG+PET+studies+in+patients+with+extratemporal+and+temporal+epilepsy:+evaluation+of+an+observer‐independent+analysis+&author=A+Drzezga&author=S+Arnold&author=S+Minoshima&author=S+Noachtar&author=J+Szecsi&author=P+Winkler&publication_year=1999&hl=en'],,, Drzezga 1999 ,additional,CD010632-bbs2-0067,
CD010632-bib-0068,"Duara R, Grady C, Haxby J, Sundaram M, Cutler N, Heston L, et al. ",Positron emission tomography in Alzheimer's disease,,1986,,    ,['citation-other']," Duara R, Grady C, Haxby J, Sundaram M, Cutler N, Heston L, et al. Positron emission tomography in Alzheimer's disease. Neurology1986; Vol. 36, issue 7:879‐87. [0028‐3878]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Positron+emission+tomography+in+Alzheimer's+disease&author=R+Duara&author=C+Grady&author=J+Haxby&author=M+Sundaram&author=N+Cutler&author=L+Heston&publication_year=1986&hl=en""]",,, Duara 1986 ,additional,CD010632-bbs2-0068,
CD010632-bib-0069,"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger‐Gateau P, Cummings J, et al. ",Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS‐ADRDA criteria, Lancet. Neurology ,2007,6,    ,['citation-journal']," Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger‐Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS‐ADRDA criteria.  Lancet. Neurology 2007;6(8):734‐46.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1474-4422(07)70178-3', ""https://scholar.google.com/scholar_lookup?title=Research+criteria+for+the+diagnosis+of+Alzheimer's+disease:+revising+the+NINCDS‐ADRDA+criteria+&author=B+Dubois&author=HH+Feldman&author=C+Jacova&author=ST+Dekosky&author=P+Barberger‐Gateau&author=J+Cummings&publication_year=2007&hl=en""]",,https://doi.org/10.1016/S1474-4422(07)70178-3, Dubois 2007 ,additional,CD010632-bbs2-0069,
CD010632-bib-0070,"Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger‐Gateau P, et al. ",Revising the definition of Alzheimer's disease: a new lexicon, Lancet. Neurology ,2010,9,    ,['citation-journal']," Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger‐Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon.  Lancet. Neurology 2010;9(11):1118‐27. [1474‐4422]    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1474-4422(10)70223-4', ""https://scholar.google.com/scholar_lookup?title=Revising+the+definition+of+Alzheimer's+disease:+a+new+lexicon&author=B+Dubois&author=HH+Feldman&author=C+Jacova&author=JL+Cummings&author=ST+DeKosky&author=P+Barberger‐Gateau&publication_year=2010&hl=en""]",,https://doi.org/10.1016/S1474-4422(10)70223-4, Dubois 2010 ,additional,CD010632-bbs2-0070,
CD010632-bib-0071,"Fellgiebel A, Siessmeier T, Scheurich A, Winterer G, Bartenstein P, Schmidt LG, at al. ",Association of elevated phospho‐tau levels with Alzheimer‐typical 18F‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography findings in patients with mild cognitive impairment, Biological Psychiatry ,2004,56,    ,['citation-journal']," Fellgiebel A, Siessmeier T, Scheurich A, Winterer G, Bartenstein P, Schmidt LG, at al. Association of elevated phospho‐tau levels with Alzheimer‐typical 18F‐Fluoro‐2‐deoxy‐D‐glucose positron emission tomography findings in patients with mild cognitive impairment.  Biological Psychiatry 2004;56(4):279‐83.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.biopsych.2004.05.014', 'https://scholar.google.com/scholar_lookup?title=Association+of+elevated+phospho‐tau+levels+with+Alzheimer‐typical+18F‐Fluoro‐2‐deoxy‐D‐glucose+positron+emission+tomography+findings+in+patients+with+mild+cognitive+impairment+&author=A+Fellgiebel&author=T+Siessmeier&author=A+Scheurich&author=G+Winterer&author=P+Bartenstein&author=LG+Schmidt&author=al+at&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.biopsych.2004.05.014, Fellgiebel 2004 ,additional,CD010632-bbs2-0071,
CD010632-bib-0072,"Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. ",Global prevalence of dementia: a Delphi consensus study,,2005,,    ,['citation-other']," Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet2005; Vol. 366, issue 9503:2112‐7. [0140‐6736]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Global+prevalence+of+dementia:+a+Delphi+consensus+study&author=CP+Ferri&author=M+Prince&author=C+Brayne&author=H+Brodaty&author=L+Fratiglioni&author=M+Ganguli&publication_year=2005&hl=en'],,, Ferri 2005 ,additional,CD010632-bbs2-0072,
CD010632-bib-0073,"Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, et al. ",Imaging markers for Alzheimer disease: which vs how, Neurology ,2013,81,    ,['citation-journal']," Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, et al. Imaging markers for Alzheimer disease: which vs how.  Neurology 2013;81(5):487‐500. [DOI: 10.1212/WNL.0b013e31829d86e8]    Link to article     Google Scholar     ","['https://doi.org/10.1212/WNL.0b013e31829d86e8', 'https://scholar.google.com/scholar_lookup?title=Imaging+markers+for+Alzheimer+disease:+which+vs+how&author=GB+Frisoni&author=M+Bocchetta&author=G+Chételat&author=GD+Rabinovici&author=MJ+Leon&author=J+Kaye&publication_year=2013&hl=en']",,https://doi.org/10.1212/WNL.0b013e31829d86e8, Frisoni 2013 ,additional,CD010632-bbs2-0073,
CD010632-bib-0074,"Geslani DM, Tierney MC, Herrmann N, Szalai JP. ",Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer’s disease,,2005,,    ,['citation-other']," Geslani DM, Tierney MC, Herrmann N, Szalai JP. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders2005; Vol. 19, issue 5‐6:383‐9. [1420‐8008]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment:+an+operational+definition+and+its+conversion+rate+to+Alzheimer’s+disease+&author=DM+Geslani&author=MC+Tierney&author=N+Herrmann&author=JP+Szalai&publication_year=2005&hl=en'],,, Geslani 2005 ,additional,CD010632-bbs2-0074,
CD010632-bib-0075,"Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. ","Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives", National Reviews. Drug Discovery ,2010,9,    ,['citation-journal']," Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives.  National Reviews. Drug Discovery 2010;9(7):560‐74.    Link to article     Google Scholar     ","['https://doi.org/10.1038/nrd3115', 'https://scholar.google.com/scholar_lookup?title=Biomarkers+for+Alzheimer’s+disease:+academic,+industry+and+regulatory+perspectives&author=H+Hampel&author=R+Frank&author=K+Broich&author=SJ+Teipel&author=RG+Katz&author=J+Hardy&publication_year=2010&hl=en']",,https://doi.org/10.1038/nrd3115, Hampel 2010 ,additional,CD010632-bbs2-0075,
CD010632-bib-0076,"Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI. ",Neocortical metabolic abnormalities precede non memory cognitive defects in early Alzheimer's‐type dementia,,1986,,    ,['citation-other']," Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI. Neocortical metabolic abnormalities precede non memory cognitive defects in early Alzheimer's‐type dementia. Archives of Neurology1986; Vol. 43, issue 9:882.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Neocortical+metabolic+abnormalities+precede+non+memory+cognitive+defects+in+early+Alzheimer's‐type+dementia+&author=JV+Haxby&author=CL+Grady&author=R+Duara&author=N+Schlageter&author=G+Berg&author=SI+Rapoport&publication_year=1986&hl=en""]",,, Haxby 1986 ,additional,CD010632-bbs2-0076,
CD010632-bib-0077,"Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al. ",Impairment of neocortical metabolism predicts progression in Alzheimer’s disease, Dementia and Geriatric Cognitive Disorders ,1999,10,    ,['citation-journal']," Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al. Impairment of neocortical metabolism predicts progression in Alzheimer’s disease.  Dementia and Geriatric Cognitive Disorders 1999;10(6):494–504.    Link to article     Google Scholar     ","['https://doi.org/10.1159/000017196', 'https://scholar.google.com/scholar_lookup?title=Impairment+of+neocortical+metabolism+predicts+progression+in+Alzheimer’s+disease&author=K+Herholz&author=A+Nordberg&author=E+Salmon&author=D+Perani&author=J+Kessler&author=R+Mielke&publication_year=1999&hl=en']",,https://doi.org/10.1159/000017196, Herholz 1999 ,additional,CD010632-bbs2-0077,
CD010632-bib-0078,"Herholz K, Salmon E, Perani D, Baron J, Holthoff V, Frölich L, et al. ",Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET,,2002,,    ,['citation-other']," Herholz K, Salmon E, Perani D, Baron J, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage2002; Vol. 17, issue 1:302‐16. [1053‐8119]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Discrimination+between+Alzheimer+dementia+and+controls+by+automated+analysis+of+multicenter+FDG+PET+&author=K+Herholz&author=E+Salmon&author=D+Perani&author=J+Baron&author=V+Holthoff&author=L+Frölich&publication_year=2002&hl=en'],,, Herholz 2002 ,additional,CD010632-bbs2-0078,
CD010632-bib-0079,"Hoffman JM, Welsh‐Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, et al. ",FDG PET imaging in patients with pathologically verified dementia, Journal of Nuclear Medicine ,2000,41,    ,['citation-journal']," Hoffman JM, Welsh‐Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, et al. FDG PET imaging in patients with pathologically verified dementia.  Journal of Nuclear Medicine 2000;41(11):1920‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=FDG+PET+imaging+in+patients+with+pathologically+verified+dementia&author=JM+Hoffman&author=KA+Welsh‐Bohmer&author=M+Hanson&author=B+Crain&author=C+Hulette&author=N+Earl&publication_year=2000&hl=en'],,, Hoffman 2000 ,additional,CD010632-bbs2-0079,
CD010632-bib-0080,World Health Organization. ,Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD‐10),,2010,,.   ,['citation-other'], World Health Organization. Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD‐10). available from apps.who.int/classifications/icd10/browse/2010/en.International (accessed 16th December 2012)2010.    ,[],,, ICD‐10 2010 ,additional,CD010632-bbs2-0080,
CD010632-bib-0081,World Health Organization. ,,Statistical Classification of Diseases and Related Health Problems 9th Revision (ICD‐9),2006,"Hospital edition, vols. 1, 2, 3",.   ,['citation-book']," World Health Organization. Statistical Classification of Diseases and Related Health Problems 9th Revision (ICD‐9). 6th Edition. Vol. Hospital edition, vols. 1, 2, 3, Los Angeles, CA: Practice Management Information Corporation (PMIC), 2006.    ",[],,, ICD‐9 2006 ,additional,CD010632-bbs2-0081,
CD010632-bib-0082,"Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. ",Statistical brain mapping of 18F‐FDG PETin Alzheimer’s disease: validation of anatomic standardization for atrophied brains, Journla of Nuclear Medicine ,2001,42,    ,['citation-journal']," Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of 18F‐FDG PETin Alzheimer’s disease: validation of anatomic standardization for atrophied brains.  Journla of Nuclear Medicine 2001;42(4):548 –57.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Statistical+brain+mapping+of+18F‐FDG+PETin+Alzheimer’s+disease:+validation+of+anatomic+standardization+for+atrophied+brains+&author=K+Ishii&author=F+Willoch&author=S+Minoshima&author=A+Drzezga&author=EP+Ficaro&author=DJ+Cross&publication_year=2001&hl=en'],,, Ishii 2001 ,additional,CD010632-bbs2-0082,
CD010632-bib-0083,"Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, et al. ",The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core, Alzheimer's & Dementia ,2010,6,    ,['citation-journal']," Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, Mathis CA, et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core.  Alzheimer's & Dementia 2010;6:221‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jalz.2010.03.003', ""https://scholar.google.com/scholar_lookup?title=The+Alzheimer's+Disease+Neuroimaging+Initiative+positron+emission+tomography+core&author=WJ+Jagust&author=D+Bandy&author=K+Chen&author=NL+Foster&author=SM+Landau&author=CA+Mathis&publication_year=2010&hl=en""]",,https://doi.org/10.1016/j.jalz.2010.03.003, Jagust 2010 ,additional,CD010632-bbs2-0083,
CD010632-bib-0084,"Jelic V, Wahlund LO, Almkvist O, Johansson SE, Shigeta M, Winblad B, Nordberg A. ",Diagnostic accuracies of quantitative EEG and PET in mild Alzheimer’s disease, Alzheimer's Reports ,1999,2,    ,['citation-journal']," Jelic V, Wahlund LO, Almkvist O, Johansson SE, Shigeta M, Winblad B, Nordberg A. Diagnostic accuracies of quantitative EEG and PET in mild Alzheimer’s disease.  Alzheimer's Reports 1999;2(5):291‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Diagnostic+accuracies+of+quantitative+EEG+and+PET+in+mild+Alzheimer’s+disease&author=V+Jelic&author=LO+Wahlund&author=O+Almkvist&author=SE+Johansson&author=M+Shigeta&author=B+Winblad&author=A+Nordberg&publication_year=1999&hl=en'],,, Jelic 1999 ,additional,CD010632-bbs2-0084,
CD010632-bib-0085,"Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ. ",Antemortem diagnosis of frontotemporal lobar degeneration, Annals of Neurology ,2005,57,    ,['citation-journal']," Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ. Antemortem diagnosis of frontotemporal lobar degeneration.  Annals of Neurology 2005;57(4):480–8.    Link to article     Google Scholar     ","['https://doi.org/10.1002/ana.20425', 'https://scholar.google.com/scholar_lookup?title=Antemortem+diagnosis+of+frontotemporal+lobar+degeneration&author=DS+Knopman&author=BF+Boeve&author=JE+Parisi&author=DW+Dickson&author=GE+Smith&author=RJ+Ivnik&publication_year=2005&hl=en']",,https://doi.org/10.1002/ana.20425, Knopman 2005 ,additional,CD010632-bbs2-0085,
CD010632-bib-0086,"Knottnerus JA, Van Weel C, Muris JWM. ",Evaluation of diagnostic procedures,,2002,,    ,['citation-other']," Knottnerus JA, Van Weel C, Muris JWM. Evaluation of diagnostic procedures. BMJ2002; Vol. 324, issue 7335:477‐80. [0959‐8138]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Evaluation+of+diagnostic+procedures&author=JA+Knottnerus&author=C+Weel&author=JWM+Muris&publication_year=2002&hl=en'],,, Knottnerus 2002 ,additional,CD010632-bbs2-0086,
CD010632-bib-0087,"Laforce R, Buteau JP, Paquet N, Verret L, Houde M, Bouchard RW. ","The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: a retrospective memory clinic study", American Journal of Alzheimer's Disease and Other Dementias ,2010,25,    ,['citation-journal']," Laforce R, Buteau JP, Paquet N, Verret L, Houde M, Bouchard RW. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: a retrospective memory clinic study.  American Journal of Alzheimer's Disease and Other Dementias 2010;25(4):324‐32.    Link to article     Google Scholar     ","['https://doi.org/10.1177/1533317510363468', 'https://scholar.google.com/scholar_lookup?title=The+value+of+PET+in+mild+cognitive+impairment,+typical+and+atypical/unclear+dementias:+a+retrospective+memory+clinic+study+&author=R+Laforce&author=JP+Buteau&author=N+Paquet&author=L+Verret&author=M+Houde&author=RW+Bouchard&publication_year=2010&hl=en']",,https://doi.org/10.1177/1533317510363468, Laforce 2010 ,additional,CD010632-bbs2-0087,
CD010632-bib-0088,"Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM. ",Systematic reviews of diagnostic test accuracy,,2008,,    ,['citation-other']," Leeflang MMG, Deeks JJ, Gatsonis C, Bossuyt PMM. Systematic reviews of diagnostic test accuracy. Annals of Internal Medicine2008; Vol. 149, issue 12:889.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Systematic+reviews+of+diagnostic+test+accuracy&author=MMG+Leeflang&author=JJ+Deeks&author=C+Gatsonis&author=PMM+Bossuyt&publication_year=2008&hl=en'],,, Leeflang 2008 ,additional,CD010632-bbs2-0088,
CD010632-bib-0089,"Lucignani G, Frost JF. ",Neurochemical imaging with emission tomography: Clinical applications,,,,. link.springer.com/chapter/10.1007/3‐540‐30005‐8_2#page‐1Diagnostic nuclear medicine (accessed January 12 2015) 2006.   ,['citation-other']," Lucignani G, Frost JF. Neurochemical imaging with emission tomography: Clinical applications. link.springer.com/chapter/10.1007/3‐540‐30005‐8_2#page‐1Diagnostic nuclear medicine (accessed January 12 2015) 2006.    ",[],,, Lucignani 2006 ,additional,CD010632-bbs2-0089,
CD010632-bib-0090,The Lund and Manchester Groups. ,Clinical and neuropathological criteria for frontotemporal dementia," Journal of Neurology, Neurosurgery and Psychiatry ",1994,57,    ,['citation-journal']," The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia.  Journal of Neurology, Neurosurgery and Psychiatry 1994;57(4):416‐8.    Link to article     ",['https://doi.org/10.1136/jnnp.57.4.416'],,https://doi.org/10.1136/jnnp.57.4.416, Lund Manchester 1994 ,additional,CD010632-bbs2-0090,
CD010632-bib-0091,"Matthews FE, Stephan B, McKeith IG, Bond J, Brayne C. ",Two‐year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?,,2008,,    ,['citation-other']," Matthews FE, Stephan B, McKeith IG, Bond J, Brayne C. Two‐year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society2008; Vol. 56, issue 8:1424‐33. [1532‐5415]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Two‐year+progression+from+mild+cognitive+impairment+to+dementia:+to+what+extent+do+different+definitions+agree?+&author=FE+Matthews&author=B+Stephan&author=IG+McKeith&author=J+Bond&author=C+Brayne&publication_year=2008&hl=en'],,, Matthews 2008 ,additional,CD010632-bbs2-0091,
CD010632-bib-0092,"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. ",CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment, JAMA ,2009,302,    ,['citation-journal']," Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.  JAMA 2009;302(4):385‐93.    Link to article     Google Scholar     ","['https://doi.org/10.1001/jama.2009.1064', 'https://scholar.google.com/scholar_lookup?title=CSF+biomarkers+and+incipient+Alzheimer+disease+in+patients+with+mild+cognitive+impairment&author=N+Mattsson&author=H+Zetterberg&author=O+Hansson&author=N+Andreasen&author=L+Parnetti&author=M+Jonsson&publication_year=2009&hl=en']",,https://doi.org/10.1001/jama.2009.1064, Mattsson 2009 ,additional,CD010632-bbs2-0092,
CD010632-bib-0093,"McKeith I, Galasko D, Kosaka K, Perry E, Dickson D, Hansen LA, et al. ",Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop,,1996,,    ,['citation-other']," McKeith I, Galasko D, Kosaka K, Perry E, Dickson D, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop. Neurology1996; Vol. 47, issue 5:1113‐24. [0028‐3878]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Consensus+guidelines+for+the+clinical+and+pathologic+diagnosis+of+dementia+with+Lewy+bodies+(DLB)+Report+of+the+consortium+on+DLB+international+workshop+&author=I+McKeith&author=D+Galasko&author=K+Kosaka&author=E+Perry&author=D+Dickson&author=LA+Hansen&publication_year=1996&hl=en'],,, McKeith 1996 ,additional,CD010632-bbs2-0093,
CD010632-bib-0094,McKeith IG. ,Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop,,2006,,    ,['citation-other']," McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Journal of Alzheimer's Disease2006; Vol. 9, issue 3 Suppl:417‐23. [1387‐2877]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Consensus+guidelines+for+the+clinical+and+pathologic+diagnosis+of+dementia+with+Lewy+bodies+(DLB):+report+of+the+Consortium+on+DLB+International+Workshop+&author=IG+McKeith&publication_year=2006&hl=en'],,, McKeith 2006 ,additional,CD010632-bbs2-0094,
CD010632-bib-0095,"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. ",Clinical diagnosis of Alzheimer's disease Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology ,1984,34,    ,['citation-journal']," McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  Neurology 1984;34(7):939‐44. [0028‐3878]    Link to article     Google Scholar     ","['https://doi.org/10.1212/WNL.34.7.939', ""https://scholar.google.com/scholar_lookup?title=Clinical+diagnosis+of+Alzheimer's+disease+Report+of+the+NINCDS‐ADRDA+Work+Group*+under+the+auspices+of+Department+of+Health+and+Human+Services+Task+Force+on+Alzheimer's+Disease+&author=G+McKhann&author=D+Drachman&author=M+Folstein&author=R+Katzman&author=D+Price&author=EM+Stadlan&publication_year=1984&hl=en""]",,https://doi.org/10.1212/WNL.34.7.939, McKhann 1984 ,additional,CD010632-bbs2-0095,
CD010632-bib-0096,"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. ",The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia ,2011,7,    ,['citation-journal']," McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimer's & Dementia 2011;7(3):263‐9. [1552‐5260]    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.jalz.2011.03.005', ""https://scholar.google.com/scholar_lookup?title=The+diagnosis+of+dementia+due+to+Alzheimer’s+disease:+Recommendations+from+the+National+Institute+on+Aging‐Alzheimer’s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer's+disease+&author=GM+McKhann&author=DS+Knopman&author=H+Chertkow&author=BT+Hyman&author=CR+Jack&author=CH+Kawas&publication_year=2011&hl=en""]",,https://doi.org/10.1016/j.jalz.2011.03.005, McKhann 2011 ,additional,CD010632-bbs2-0096,
CD010632-bib-0097,"McShane R, Areosa Sastre A, Minakaran N. ",Memantine for dementia, Cochrane Database of Systematic Reviews ,2006,,    ,['citation-journal']," McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia.  Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD003154.pub5]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD003154.pub5', 'https://scholar.google.com/scholar_lookup?title=Memantine+for+dementia&author=R+McShane&author=A+AreosaSastre&author=N+Minakaran&publication_year=2006&hl=en']",,https://doi.org/10.1002/14651858.CD003154.pub5, McShane 2006 ,additional,CD010632-bbs2-0097,
CD010632-bib-0098,"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. ",A diagnostic approach in Alzheimer's disease using three‐dimensional stereotactic surface projections of fluorine‐18‐FDG PET, Journal of Nuclear Medicine ,1995,36,    ,['citation-journal']," Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three‐dimensional stereotactic surface projections of fluorine‐18‐FDG PET.  Journal of Nuclear Medicine 1995;36(7):1238‐48.    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=A+diagnostic+approach+in+Alzheimer's+disease+using+three‐dimensional+stereotactic+surface+projections+of+fluorine‐18‐FDG+PET+&author=S+Minoshima&author=KA+Frey&author=RA+Koeppe&author=NL+Foster&author=DE+Kuhl&publication_year=1995&hl=en""]",,, Minoshima 1995 ,additional,CD010632-bbs2-0098,
CD010632-bib-0099,Morris JC. ,The Clinical Dementia Rating (CDR): current version and scoring rules, Neurology; Neurology ,1993,43,    ,['citation-journal'], Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules.  Neurology; Neurology 1993;43(11):2412‐4. [1526‐632X]    Link to article     Google Scholar     ,"['https://doi.org/10.1212/WNL.43.11.2412-a', 'https://scholar.google.com/scholar_lookup?title=The+Clinical+Dementia+Rating+(CDR):+current+version+and+scoring+rules&author=JC+Morris&publication_year=1993&hl=en']",,https://doi.org/10.1212/WNL.43.11.2412-a, Morris 1993 ,additional,CD010632-bbs2-0099,
CD010632-bib-0100,"Morris JC, Price JL. ","Pathologic correlates of non demented aging, mild cognitive impairment, and early‐stage Alzheimer’s disease",,2001,,    ,['citation-other']," Morris JC, Price JL. Pathologic correlates of non demented aging, mild cognitive impairment, and early‐stage Alzheimer’s disease. Journal of Molecular Neuroscience2001; Vol. 17, issue 2:101‐18. [0895‐8696]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Pathologic+correlates+of+non+demented+aging,+mild+cognitive+impairment,+and+early‐stage+Alzheimer’s+disease+&author=JC+Morris&author=JL+Price&publication_year=2001&hl=en']",,, Morris 2001 ,additional,CD010632-bbs2-0100,
CD010632-bib-0101,Mosconi L. ,FDG PET in the evaluation of mild cognitive impairment and early dementia,PET in the Evaluation of Alzheimer's Disease and Related Disorders,2009,,    ,['citation-book']," Mosconi L. FDG PET in the evaluation of mild cognitive impairment and early dementia. In: Silverman D editor(s). PET in the Evaluation of Alzheimer's Disease and Related Disorders. Springer, 2009:49‐65. [0387764194]    Link to article     Google Scholar     ","['https://doi.org/10.1007/978-0-387-76420-7_3', 'https://scholar.google.com/scholar_lookup?title=FDG+PET+in+the+evaluation+of+mild+cognitive+impairment+and+early+dementia&author=L+Mosconi&publication_year=2009&hl=en']",,https://doi.org/10.1007/978-0-387-76420-7_3, Mosconi 2009 ,additional,CD010632-bbs2-0101,
CD010632-bib-0102,"Moulin‐Romsee G, Maes A, Silverman D, Mortelmans L, Van Laere K. ",Cost‐effectiveness of 18F‐fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective, European Journal of Neurology ,2005,12,    ,['citation-journal']," Moulin‐Romsee G, Maes A, Silverman D, Mortelmans L, Van Laere K. Cost‐effectiveness of 18F‐fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective.  European Journal of Neurology 2005;12(4):254‐63.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1468-1331.2004.00940.x', 'https://scholar.google.com/scholar_lookup?title=Cost‐effectiveness+of+18F‐fluorodeoxyglucose+positron+emission+tomography+in+the+assessment+of+early+dementia+from+a+Belgian+and+European+perspective+&author=G+Moulin‐Romsee&author=A+Maes&author=D+Silverman&author=L+Mortelmans&author=K+Laere&publication_year=2005&hl=en']",,https://doi.org/10.1111/j.1468-1331.2004.00940.x, Moulin‐Romsee 2005 ,additional,CD010632-bbs2-0102,
CD010632-bib-0103,National Audit Office. ,Improving Services and Support for People with Dementia,,2007,,.   ,['citation-other'], National Audit Office. Improving Services and Support for People with Dementia. www.nao.org.uk/wp‐content/uploads/2007/07/0607604.pdf2007.    ,[],,, NAO 2007 ,additional,CD010632-bbs2-0103,
CD010632-bib-0104,"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. ",Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria,,1998,,    ,['citation-other']," Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology1998; Vol. 51, issue 6:1546‐54. [0028‐3878]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Frontotemporal+lobar+degeneration:+a+consensus+on+clinical+diagnostic+criteria&author=D+Neary&author=JS+Snowden&author=L+Gustafson&author=U+Passant&author=D+Stuss&author=S+Black&publication_year=1998&hl=en'],,, Neary 1998 ,additional,CD010632-bbs2-0104,
CD010632-bib-0105,"Nitrini R, Buchpiguel C, Caramelli P, Bahia V, Mathias S, Nascimento C, et al. ",SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion,,2000,,    ,['citation-other']," Nitrini R, Buchpiguel C, Caramelli P, Bahia V, Mathias S, Nascimento C, et al. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion. Acta Neurologica Scandinavica2000; Vol. 101, issue 3:172‐6. [1600‐0404]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=SPECT+in+Alzheimer's+disease:+features+associated+with+bilateral+parietotemporal+hypoperfusion&author=R+Nitrini&author=C+Buchpiguel&author=P+Caramelli&author=V+Bahia&author=S+Mathias&author=C+Nascimento&publication_year=2000&hl=en""]",,, Nitrini 2000 ,additional,CD010632-bbs2-0105,
CD010632-bib-0106,"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. ","Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome",,2004,,    ,['citation-other']," Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron2004; Vol. 43, issue 3:321‐32.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Abeta+immunotherapy+leads+to+clearance+of+early,+but+not+late,+hyperphosphorylated+tau+aggregates+via+the+proteasome+&author=S+Oddo&author=L+Billings&author=JP+Kesslak&author=DH+Cribbs&author=FM+LaFerla&publication_year=2004&hl=en']",,, Oddo 2004 ,additional,CD010632-bbs2-0106,
CD010632-bib-0107,"Okello A, Edison P, Archer H, Turkheimer F, Kennedy J, Bullock R, et al. ",Microglial activation and amyloid deposition in mild cognitive impairment: a PET study,,2009,,    ,['citation-other']," Okello A, Edison P, Archer H, Turkheimer F, Kennedy J, Bullock R, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology2009; Vol. 72, issue 1:56‐62. [0028‐3878]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Microglial+activation+and+amyloid+deposition+in+mild+cognitive+impairment:+a+PET+study&author=A+Okello&author=P+Edison&author=H+Archer&author=F+Turkheimer&author=J+Kennedy&author=R+Bullock&publication_year=2009&hl=en'],,, Okello 2009 ,additional,CD010632-bbs2-0107,
CD010632-bib-0108,"Patterson JC, Lilien DL, Takalkar A, Pinkston JB. ",Early detection of brain pathology suggestive of early AD using objective evaluation of FDG‐PET scans,,2010,,    ,['citation-other']," Patterson JC, Lilien DL, Takalkar A, Pinkston JB. Early detection of brain pathology suggestive of early AD using objective evaluation of FDG‐PET scans. International Journal of Alzheimer's Disease2010; Vol. 2011:ii. 946590. [DOI: 10.4061/2011/946590]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Early+detection+of+brain+pathology+suggestive+of+early+AD+using+objective+evaluation+of+FDG‐PET+scans+&author=JC+Patterson&author=DL+Lilien&author=A+Takalkar&author=JB+Pinkston&publication_year=2010&hl=en'],,, Patterson 2010 ,additional,CD010632-bbs2-0108,
CD010632-bib-0109,"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. ",Mild cognitive impairment: clinical characterization and outcome,,1999,,    ,['citation-other']," Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology1999; Vol. 56, issue 3:303‐8.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment:+clinical+characterization+and+outcome&author=RC+Petersen&author=GE+Smith&author=SC+Waring&author=RJ+Ivnik&author=EG+Tangalos&author=E+Kokmen&publication_year=1999&hl=en'],,, Petersen 1999 ,additional,CD010632-bbs2-0109,
CD010632-bib-0110,"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. ",Current concepts in mild cognitive impairment,,2001,,    ,['citation-other']," Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Archives of Neurology2001; Vol. 58, issue 12:1985‐92.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Current+concepts+in+mild+cognitive+impairment&author=RC+Petersen&author=R+Doody&author=A+Kurz&author=RC+Mohs&author=JC+Morris&author=PV+Rabins&publication_year=2001&hl=en'],,, Petersen 2001 ,additional,CD010632-bbs2-0110,
CD010632-bib-0111,Petersen RC. ,Conceptual overview,Mild Cognitive Impairment: Aging to Alzheimer’s Disease,2003,,    ,['citation-book']," Petersen RC. Conceptual overview. In: Petersen RC editor(s). Mild Cognitive Impairment: Aging to Alzheimer’s Disease. New York:: Oxford University Press, 2003:1‐14.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Conceptual+overview&author=RC+Petersen&publication_year=2003&hl=en'],,, Petersen 2003 ,additional,CD010632-bbs2-0111,
CD010632-bib-0112,Petersen RC. ,Mild cognitive impairment as a diagnostic entity,,2004,,    ,['citation-other']," Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine2004; Vol. 256, issue 3:183‐94. [1365‐2796]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment+as+a+diagnostic+entity&author=RC+Petersen&publication_year=2004&hl=en'],,, Petersen 2004 ,additional,CD010632-bbs2-0112,
CD010632-bib-0113,"Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. ",Mild cognitive impairment: ten years later,,2009,,    ,['citation-other']," Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild cognitive impairment: ten years later. Archives of Neurology2009; Vol. 66, issue 12:1447‐55.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment:+ten+years+later&author=RC+Petersen&author=RO+Roberts&author=DS+Knopman&author=BF+Boeve&author=YE+Geda&author=RJ+Ivnik&publication_year=2009&hl=en'],,, Petersen 2009 ,additional,CD010632-bbs2-0113,
CD010632-bib-0114,"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. ",Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical characterization, Neurology ,2010,74,    ,['citation-journal']," Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): Clinical characterization.  Neurology 2010;74(3):201‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1212/WNL.0b013e3181cb3e25', 'https://scholar.google.com/scholar_lookup?title=Alzheimer’s+Disease+Neuroimaging+Initiative+(ADNI):+Clinical+characterization&author=RC+Petersen&author=PS+Aisen&author=LA+Beckett&author=MC+Donohue&author=AC+Gamst&author=DJ+Harvey&publication_year=2010&hl=en']",,https://doi.org/10.1212/WNL.0b013e3181cb3e25, Petersen 2010 ,additional,CD010632-bbs2-0114,
CD010632-bib-0115,"Quinn TJ, Fearon P, Noel‐Storr AH, Young C, McShane R, Stott DJ. ",Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Quinn TJ, Fearon P, Noel‐Storr AH, Young C, McShane R, Stott DJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within community dwelling populations.  Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD010079]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD010079.pub2', 'https://scholar.google.com/scholar_lookup?title=Informant+Questionnaire+on+Cognitive+Decline+in+the+Elderly+(IQCODE)+for+the+diagnosis+of+dementia+within+community+dwelling+populations+&author=TJ+Quinn&author=P+Fearon&author=AH+Noel‐Storr&author=C+Young&author=R+McShane&author=DJ+Stott&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD010079.pub2, Quinn 2014 ,additional,CD010632-bbs2-0115,
CD010632-bib-0116,"Reisberg B, Ferris SH, De Leon MJ. Crook T. ",The Global Deterioration Scale for assessment of primary degenerative dementia, American Journal of Psychiatry ,1982,139,    ,['citation-journal']," Reisberg B, Ferris SH, De Leon MJ. Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia.  American Journal of Psychiatry 1982;139(9):1136‐9.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+Global+Deterioration+Scale+for+assessment+of+primary+degenerative+dementia&author=B+Reisberg&author=SH+Ferris&author=T+LeonMJ.Crook&publication_year=1982&hl=en'],,, Reisberg 1982 ,additional,CD010632-bbs2-0116,
CD010632-bib-0117,"Román GC, Tatemichi TK, Erkinjuntti T, Cummings J, Masdeu J, Garcia JH, et al. ",Vascular dementia diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop,,1993,,    ,['citation-other']," Román GC, Tatemichi TK, Erkinjuntti T, Cummings J, Masdeu J, Garcia JH, et al. Vascular dementia diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop. Neurology1993; Vol. 43, issue 2:250‐60. [0028‐3878]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Vascular+dementia+diagnostic+criteria+for+research+studies:+Report+of+the+NINDS‐AIREN+International+Workshop+&author=GC+Román&author=TK+Tatemichi&author=T+Erkinjuntti&author=J+Cummings&author=J+Masdeu&author=JH+Garcia&publication_year=1993&hl=en'],,, Román 1993 ,additional,CD010632-bbs2-0117,
CD010632-bib-0118,"Rosen WG, Mohs RC, Davis KL. ",A new rating scale forAlzheimer’s disease, American Journal of Psychiatry ,1984,141,    ,['citation-journal']," Rosen WG, Mohs RC, Davis KL. A new rating scale forAlzheimer’s disease.  American Journal of Psychiatry 1984;141(11):1356–64.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=A+new+rating+scale+forAlzheimer’s+disease&author=WG+Rosen&author=RC+Mohs&author=KL+Davis&publication_year=1984&hl=en'],,, Rosen 1984 ,additional,CD010632-bbs2-0118,
CD010632-bib-0119,"Rutter CM, Gatsonis CA. ",A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations,,2001,,    ,['citation-other']," Rutter CM, Gatsonis CA. A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations. Statistics in Medicine2001; Vol. 20, issue 19:2865‐84. [1097‐0258]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=A+hierarchical+regression+approach+to+meta‐analysis+of+diagnostic+test+accuracy+evaluations&author=CM+Rutter&author=CA+Gatsonis&publication_year=2001&hl=en'],,, Rutter 2001 ,additional,CD010632-bbs2-0119,
CD010632-bib-0120,"Schroeter ML, Stein T, Maslowski N, Neumann J. ",Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta‐analysis involving 1351 patients,,2009,,    ,['citation-other']," Schroeter ML, Stein T, Maslowski N, Neumann J. Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta‐analysis involving 1351 patients. NeuroImage2009; Vol. 47, issue 4:1196‐206. [1053‐8119]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Neural+correlates+of+Alzheimer's+disease+and+mild+cognitive+impairment:+a+systematic+and+quantitative+meta‐analysis+involving+1351+patients+&author=ML+Schroeter&author=T+Stein&author=N+Maslowski&author=J+Neumann&publication_year=2009&hl=en""]",,, Schroeter 2009 ,additional,CD010632-bbs2-0120,
CD010632-bib-0121,"Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, et al. ",Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits, Journal of Nuclear Medicine ,2002,43,    ,['citation-journal']," Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits.  Journal of Nuclear Medicine 2002;43(2):253‐66.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Evaluating+early+dementia+with+and+without+assessment+of+regional+cerebral+metabolism+by+PET:+a+comparison+of+predicted+costs+and+benefits+&author=DH+Silverman&author=SS+Gambhir&author=HW+Huang&author=J+Schwimmer&author=S+Kim&author=GW+Small&publication_year=2002&hl=en'],,, Silverman 2002 ,additional,CD010632-bbs2-0121,
CD010632-bib-0122,"Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. ",Positron emission tomography in evaluation of dementia: Regional brain metabolism and long‐term outcome, JAMA ,2001,286,    ,['citation-journal']," Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long‐term outcome.  JAMA 2001;286(17):2120‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1001/jama.286.17.2120', 'https://scholar.google.com/scholar_lookup?title=Positron+emission+tomography+in+evaluation+of+dementia:+Regional+brain+metabolism+and+long‐term+outcome+&author=DH+Silverman&author=GW+Small&author=CY+Chang&author=CS+Lu&author=MA+KungDeAburto&author=W+Chen&publication_year=2001&hl=en']",,https://doi.org/10.1001/jama.286.17.2120, Silverman 2001 ,additional,CD010632-bbs2-0122,
CD010632-bib-0123,Silverman DHS. ,"Clinical interpretation of brain PET scans: performing visual assessments, providing quantifying data, and generating integrated reports",PET in the Evaluation of Alzheimer’s Disease and Related Disorders,2009,,    ,['citation-book']," Silverman DHS. Clinical interpretation of brain PET scans: performing visual assessments, providing quantifying data, and generating integrated reports. In: Silverman DHS editor(s). PET in the Evaluation of Alzheimer’s Disease and Related Disorders. New York: Springer, 2009:33‐49.    Link to article     Google Scholar     ","['https://doi.org/10.1007/978-0-387-76420-7_2', 'https://scholar.google.com/scholar_lookup?title=Clinical+interpretation+of+brain+PET+scans:+performing+visual+assessments,+providing+quantifying+data,+and+generating+integrated+reports+&author=DHS+Silverman&publication_year=2009&hl=en']",,https://doi.org/10.1007/978-0-387-76420-7_2, Silverman 2009 ,additional,CD010632-bbs2-0123,
CD010632-bib-0124,"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. ",Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease,,2011,,    ,['citation-other']," Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia2011; Vol. 7, issue 3:280‐92. [1552‐5260]    Google Scholar     ","[""https://scholar.google.com/scholar_lookup?title=Toward+defining+the+preclinical+stages+of+Alzheimer’s+disease:+Recommendations+from+the+National+Institute+on+Aging‐Alzheimer's+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer's+disease+&author=RA+Sperling&author=PS+Aisen&author=LA+Beckett&author=DA+Bennett&author=S+Craft&author=AM+Fagan&publication_year=2011&hl=en""]",,, Sperling 2011 ,additional,CD010632-bbs2-0124,
CD010632-bib-0125,"Varrone A, Asenbaum S, Vander Borght V, Booij J, Nobili F, Någren K, et al. ","EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2", European Journal of Nuclear Medicine and Molecular Imaging ,2009,36,    ,['citation-journal']," Varrone A, Asenbaum S, Vander Borght V, Booij J, Nobili F, Någren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.  European Journal of Nuclear Medicine and Molecular Imaging 2009;36(12):2103‐10.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s00259-009-1264-0', 'https://scholar.google.com/scholar_lookup?title=EANM+procedure+guidelines+for+PET+brain+imaging+using+[18F]FDG,+version+2&author=A+Varrone&author=S+Asenbaum&author=V+VanderBorght&author=J+Booij&author=F+Nobili&author=K+Någren&publication_year=2009&hl=en']",,https://doi.org/10.1007/s00259-009-1264-0, Varrone 2009 ,additional,CD010632-bbs2-0125,
CD010632-bib-0126,"Visser PJ, Kester A, Jolles J, Verhey F. ",Ten‐year risk of dementia in subjects with mild cognitive impairment,,2006,,    ,['citation-other']," Visser PJ, Kester A, Jolles J, Verhey F. Ten‐year risk of dementia in subjects with mild cognitive impairment. Neurology2006; Vol. 67, issue 7:1201‐7. [0028‐3878]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Ten‐year+risk+of+dementia+in+subjects+with+mild+cognitive+impairment&author=PJ+Visser&author=A+Kester&author=J+Jolles&author=F+Verhey&publication_year=2006&hl=en'],,, Visser 2006 ,additional,CD010632-bbs2-0126,
CD010632-bib-0127,"Waxman A, Herholz K, Lewis D, Herscovitch P, Minoshima S, Ichise M, et al. ",Society of Nuclear Medicine procedure guideline for FDG PET brain imaging,,,,. interactive.snm.org/docs/FDG_brain_perfusion_V0%203%20(10‐1)%20Final.pdf (accessed 12th January 2015) 2009.   ,['citation-other']," Waxman A, Herholz K, Lewis D, Herscovitch P, Minoshima S, Ichise M, et al. Society of Nuclear Medicine procedure guideline for FDG PET brain imaging. interactive.snm.org/docs/FDG_brain_perfusion_V0%203%20(10‐1)%20Final.pdf (accessed 12th January 2015) 2009.    ",[],,, Waxman 2009 ,additional,CD010632-bbs2-0127,
CD010632-bib-0128,"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al: QUADAS‐2 Group. ",QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies, Annals of Internal Medicine ,2011,155,    ,['citation-journal']," Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al: QUADAS‐2 Group. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies.  Annals of Internal Medicine 2011;155(8):529‐36.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-155-8-201110180-00009', 'https://www.ncbi.nlm.nih.gov/pubmed/22007046', 'https://scholar.google.com/scholar_lookup?title=QUADAS‐2:+a+revised+tool+for+the+quality+assessment+of+diagnostic+accuracy+studies&author=PF+Whiting&author=AW+Rutjes&author=ME+Westwood&author=S+Mallett&author=JJ+Deeks&author=JB+Reitsma&publication_year=2011&hl=en']",22007046,https://doi.org/10.7326/0003-4819-155-8-201110180-00009, Whiting 2011 ,additional,CD010632-bbs2-0128,
CD010632-bib-0129,"Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. ","Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment",,2004,,    ,['citation-other']," Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine2004; Vol. 256, issue 3:240‐6. [1365‐2796]    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Mild+cognitive+impairment–beyond+controversies,+towards+a+consensus:+report+of+the+International+Working+Group+on+Mild+Cognitive+Impairment+&author=B+Winblad&author=K+Palmer&author=M+Kivipelto&author=V+Jelic&author=L+Fratiglioni&author=LO+Wahlund&publication_year=2004&hl=en']",,, Winblad 2004 ,additional,CD010632-bbs2-0129,
CD010632-bib-0130,"Vacante M, Smailagic N, Sachpekidis C, Hyde C, Martin S, Ukoumunne O. ",The accuracy of 18FDG‐PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI, Cochrane Database of Systematic Reviews ,2013,,    ,['citation-journal']," Vacante M, Smailagic N, Sachpekidis C, Hyde C, Martin S, Ukoumunne O. The accuracy of 18FDG‐PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI.  Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD010632]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD010632', 'https://scholar.google.com/scholar_lookup?title=The+accuracy+of+18FDG‐PET+in+the+early+diagnosis+of+Alzheimer’s+disease+dementia+and+other+dementias+in+people+with+MCI+&author=M+Vacante&author=N+Smailagic&author=C+Sachpekidis&author=C+Hyde&author=S+Martin&author=O+Ukoumunne&publication_year=2013&hl=en']",,https://doi.org/10.1002/14651858.CD010632, Vacante 2013 ,other_versions,CD010632-bbs2-0130,
